US20020033177A1 - Inhalant medicator - Google Patents

Inhalant medicator Download PDF

Info

Publication number
US20020033177A1
US20020033177A1 US09/998,418 US99841801A US2002033177A1 US 20020033177 A1 US20020033177 A1 US 20020033177A1 US 99841801 A US99841801 A US 99841801A US 2002033177 A1 US2002033177 A1 US 2002033177A1
Authority
US
United States
Prior art keywords
medical powder
medicator
inflow
cylindrical
powder storage
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
US09/998,418
Inventor
Hisatomo Ohki
Yoshiyuki Yazama
Shigemi Nakamura
Kazunori Ishizeki
Akira Yanagawa
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to US09/998,418 priority Critical patent/US20020033177A1/en
Publication of US20020033177A1 publication Critical patent/US20020033177A1/en
Abandoned legal-status Critical Current

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00Inhalators
    • A61M15/0028Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00Inhalators
    • A61M15/0028Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up
    • A61M15/003Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up using capsules, e.g. to be perforated or broken-up
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2202/00Special media to be introduced, removed or treated
    • A61M2202/06Solids
    • A61M2202/064Powder
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2206/00Characteristics of a physical parameter; associated device therefor
    • A61M2206/10Flow characteristics
    • A61M2206/16Rotating swirling helical flow, e.g. by tangential inflows

Definitions

  • the invention relates to an inhalant medicator suitable to prescribe granular or powdered medicines (medical powder) toward within lungs of a patient by way of breathing action of the patient.
  • the inhalant medicator as disclosed in the above Japanese Patent Provisional Publication is generally comprised of a medicator body equipped at one axial end with a capsule housing hole and at the other axial end with an inhalant port, an inflow air passageway formed in the medicator body for flowing air into the capsule housing hole, an outflow air passageway formed in the medicator body for flowing medical powder stored in the capsule of the capsule housing hole together with airflown through the inflow air passageway into the inhalant port, pin insertion holes located at both sides of the capsule housing hole in the axial directions of the capsule housing hole and bored in the medicator body in such a manner as to extend in a radial direction of the medicator body for communicating each of the inflow and outflow air passageways, and a boring tool having pins insertable toward the capsule through the respective pin insertion holes for breaking through the capsule accommodated in the capsule housing hole.
  • the capsule is accommodated in the capsule housing hole, and holes, communicating the internal space of the capsule with each of the air passageways, are pricked or punched by means of the boring tool.
  • the patient draws his or her breath while taking the inhalant port in his or her mouse, and thus air is flown from the atmospheric side through the inflow air passageway into the capsule.
  • the air flow carries and discharges the medical powder stored in the capsule through the outflow air passageway into the inhalant port. In this manner, the medical powder flowing out of the capsule can be inhaled through the inhalant port into the lungs of the patient.
  • the conventional inhalant medicator described above is constructed so that a capsule is inserted into a capsule housing hole of a medicator body, and the medical powder stored in the capsule is inhaled by pricking or punching holes in the capsules by way of a boring tool.
  • a boring tool For the reasons set forth above, there is the necessity for pin insertion holes and the boring tool. This increases the number of component parts, and induces a complicated structure. Thus, there are some problems, such as increased production costs and increased economical burden of a patient.
  • an object of the present invention to provide an inhalant medicator which is capable of reducing production costs by reducing the number of component parts and by simplifying its structure.
  • an inhalant medicator comprises a medicator body formed with a cylindrical fit hole opening at one axial end and formed at the other axial end with an inhalant port, an inflow air passageway formed in the medicator body for supplying air into the cylindrical fit hole, an outflow air passageway formed in the medicator body for discharging air from the cylindrical fit hole into the inhalant port, and a medical powder storage cylindrical member having a cylindrical portion defining therein a medical powder storage hole whose internal space stores a medical powder and capable of opening and closing each of the inflow air passageway and the outflow air passageway with respect to the medical powder storage hole by external operation.
  • the inhalant medicator as constructed above, under a condition where the inflow air passageway and the outflow air passageway are closed with respect to the medical powder storage hole by means of the medical powder storage cylindrical member, it is possible to prevent the medical powder stored in the medical powder storage hole from flowing to the outside via the air passageways.
  • the inflow air passageway and the outflow air passageway are communicated with the medical powder storage hole by operating the medical powder storage cylindrical member. Under these conditions, the patient draws his or her breath while taking the inhalant port in his or her mouse, atmosphere flown into the inflow air passageway flows into the medical powder storage hole, taking the form of air flow.
  • the medical powder in the medical powder storage hole can be atomized.
  • the mixture of the incoming air and medical powder passes through the outflow air passageway and then flows towards within the inhalant port, and then the mixture is inhaled through the inhalant port into lungs of the patient.
  • the inhalant medicator of the invention is constructed by two component parts, namely the medicator body and the medical powder storage cylindrical member, and also it is possible to open and close each of the air passageways with respect to the medical powder storage hole by means of the medical powder storage cylindrical member, thus ensuring a simple structure of the medicator. This reduces production costs. Additionally, even when the medical powder storage hole is filled with granular or powdered medicines in advance, it is possible to prevent the medical powder stored in the medical powder storage hole from flowing to the outside.
  • At least one medical powder diffusion chamber is formed in the medicator body and located between the cylindrical fit hole and the inhalant port for diffusing the medical powder flowing out of the outflow air passageway.
  • the inhalant medicator as constructed above, when the patient draws his or her breath while taking the inhalant port in his or her mouse, the medical powder flowing from the medical powder storage hole via the outflow air passageway can be further diffused through the medical powder diffusion chamber, and thus the medical powder can flow into the inhalant port in a finely atomized fashion.
  • the air passageway communicating with the medical powder diffusion chamber is formed to open to the medical powder diffusion chamber at an eccentric position in which the air passageway extends in a tangential direction of the medical powder diffusion chamber.
  • the inflow air passageway eccentrically arranged in the tangential direction of the medical powder diffusion chamber produces whirling flow within the medical powder diffusion chamber.
  • the medical powder storage cylindrical member is constructed by a cylindrical portion rotatably fitted into the inner peripheral wall of the cylindrical fit hole and a knob portion provided at the cylindrical portion and operated rotatably with respect to the medicator body, and inflow and outflow outlet ports through which the inflow and outflow air passageways are opened or closed by way of rotary operation of the knob portion.
  • the inflow and outflow air passageways can be respectively opened or closed by means of the inflow outlet port and the outflow outlet port by rotating the medical powder storage cylindrical member relative to the medicator body while grasping the knob portion.
  • the medical powder storage cylindrical member is constructed by a cylindrical portion axially slidably fitted into the inner peripheral wall of the cylindrical fit hole, a knob portion provided at the cylindrical portion and capable of taking out or putting in with respect to the medicator body, and inflow and outflow outlet ports through which the inflow and outflow air passageways are opened or closed by way of taking-out or putting-in operation of the knob portion.
  • the inflow and outflow air passageways can be respectively opened or closed through the inflow outlet port and the outflow outlet port by taking out or putting in the medical powder storage cylindrical member relative to the medicator body, while grasping the knob portion.
  • a stopper means is provided between the medicator body and the medical powder storage cylindrical member for positioning the medical powder storage cylindrical member at a position where the inflow outlet port is communicated with the inflow air passageway and the outflow outlet port is communicated with the outflow air passageway when operating the medical powder storage cylindrical member.
  • the stopper means when operating the medical powder storage cylindrical member, can position the medical powder storage cylindrical member at the position where the inflow outlet port and the inflow air passageway are communicated with each other and the outflow outlet port and the outflow air passageway are communicated with each other.
  • the stopper means when operating the medical powder storage cylindrical member, can position the medical powder storage cylindrical member at the position where the inflow outlet port and the inflow air passageway are communicated with each other and the outflow outlet port and the outflow air passageway are communicated with each other.
  • FIG. 1 is a longitudinal cross-sectional view illustrating a first embodiment of an inhalant medicator made according to the invention.
  • FIG. 2 is an enlarged lateral cross-sectional view illustrating a medicator body, a cylindrical portion, an inflow air passageway (an outflow air passageway), and others as viewed from the arrow indicated by II-II shown in FIG. 1.
  • FIG. 3 is an enlarged lateral cross-sectional view illustrating a medicator body, an outflow air passageway, and others as viewed from the arrow indicated by III-III shown in FIG. 1.
  • FIG. 4 is an enlarged perspective view illustrating the appearance of a medical powder storage cylindrical member.
  • FIG. 5 is an enlarged perspective view illustrating an essential part of a stopper mechanism provided at the medicator body and the knob portion of the medical powder storage cylindrical member.
  • FIG. 6 is an enlarged lateral cross-sectional view illustrating a state of the air passageway formed in the medicator body and the outlet port formed in the cylindrical portion of the medical powder storage cylindrical member, spaced to each other in the circumferential direction, as viewed from the same position as FIG. 2.
  • FIG. 7 is a longitudinal cross-sectional view illustrating the inhalant medicator under a particular condition in which medical powders are inhaled, as viewed from the same position as FIG. 1.
  • FIG. 8 is a longitudinal cross-sectional view illustrating a second embodiment of an inhalant medicator made according to the invention.
  • FIG. 9 is a longitudinal cross-sectional view illustrating a third embodiment of an inhalant medicator made according to the invention.
  • FIG. 10 is an enlarged lateral cross-sectional view illustrating the medicator body, a first outflow air passageway and others, as viewed from the arrow indicated by X-X shown in FIG. 9.
  • FIG. 11 is an enlarged lateral cross-sectional view illustrating the medicator body, a second outflow air passageway and others, as viewed from the arrow indicated by XI-XI shown in FIG. 9.
  • FIG. 12 is a longitudinal cross-sectional view illustrating the inhalant medicator under a particular condition in which a medical powder is inhaled, as viewed from the same position as FIG. 9.
  • FIG. 13 is a longitudinal cross-sectional view illustrating a fourth embodiment of an inhalant medicator made according to the invention.
  • FIG. 14 is an enlarged cross-sectional view illustrating an essential part of the inhalant medicator in an engaged state between a C-shaped groove of the cylindrical fit hole and an engaged protruded portion of the medical powder storage cylindrical member, as viewed from the arrow indicated by XIV-XIV shown in FIG. 9.
  • FIG. 15 is a longitudinal cross-sectional view illustrating the inhalant medicator in an inhalation state of medical powder with the medical powder storage cylindrical member extracted from the medicator body, as viewed from the same position as FIG. 13.
  • FIG. 16 is a longitudinal cross-sectional view illustrating an inhalant medicator corresponding to a first modification of the invention.
  • FIG. 17 is a longitudinal cross-sectional view illustrating only a medical powder storage cylindrical member corresponding to a second modification of the invention.
  • Reference sign 1 denotes a cylindrical medicator body constructing an essential part of the inhalant medicator.
  • the medicator body 1 is formed with a cylindrical fit hole 2 as described later, an inhalant port 3 , an inflow air passageway 5 , an outflow air passageway 6 , and others.
  • a portion denoted by reference sign 2 is the cylindrical fit hole formed in the medicator body 1 at one axial end.
  • the cylindrical fit hole 2 has an axially extending bore opening at the one axial end face 1 A and having a circular shape in cross section and having a bottom.
  • the bottom portion 2 A of the cylindrical fit hole is formed as a spherical surface.
  • the bottom portion 2 A of the cylindrical fit hole 2 is formed with an annular recessed groove 2 B.
  • the annular recessed groove 2 B is configured so that an annular protruded portion 9 A formed at the tip end portion of a cylindrical portion 9 of a medical powder storage cylindrical member 8 , which will be described later.
  • a portion denoted by reference sign 3 is the inhalant port formed at the other axial end of the medicator body 1 .
  • the inhalant port 3 is formed and configured in such a manner as to gradually diametrically enlarged in the other axial direction. Additionally, the inner part of the inhalant port 3 is formed with a medical powder diffusion chamber 4 , which will be described later.
  • a portion denoted by reference sign 4 is the medical powder diffusion chamber located between the cylindrical fit hole 2 and the inhalant port 3 and formed in the medicator body 1 .
  • the medical powder diffusion chamber 4 is formed as a cylindrical space axially extending toward the inhalant port 3 , so that whirling flow is produced by way of air flow of air flowing through the inflow air passageway which will be described later.
  • Portions denoted by reference signs 5 , 5 are two inflow air passageways formed in one axial end of the medicator body 1 .
  • each of the inflow air passageways 5 is constructed by axially-extending axial passages 5 A, SA located on the outer periphery of the cylindrical fit hole 2 and opening to the atmosphere at the one axial end face 1 A, and radial passages 5 B, 5 B communicating the respective axial passages 5 A and extending in the radial direction of the medicator body 1 and opening to the cylindrical fit bore 2 .
  • Portions denoted by reference signs 6 , 6 are two outflow air passageways formed in a substantially middle portion of the medicator body 1 (as viewed from the axial direction of the medicator body).
  • Each of the outflow air passageways 6 is constructed by radial air passageways 6 A, 6 A extending in the radial direction of the medicator body 1 and opening to the cylindrical fit hole 2 , and axial passages 6 B, 6 B communicating the respective tip end portions of the radial passages 6 A and extending in two opposite axial directions, and diffusion chamber inflow passages 6 C, 6 C formed as radial passages extending radially from the respective tip end portions of the axial passages 6 B and opening to the diffusion chamber 4 .
  • the diffusion chamber inflow passage 6 C of the inflow air passageway 6 opening to the medical powder diffusion chamber 4 , is formed so that its tip end portion opens at an eccentric position in which the inflow passage extends in the tangential direction of the medical powder diffusion chamber 4 .
  • air flow flowing through the diffusion chamber inflow passage 6 C into the medical powder diffusion chamber 4 becomes changed or converted into whirling flow, thus finely atomizing a lump of granular or powdered medicines 16 adhered to each other due to aggregation, condensation or the like.
  • Portions denoted by reference signs 7 , 7 are two auxiliary air passageways located on the outer periphery of the cylindrical fit hole 2 and formed in the medicator body 1 . As shown in FIG. 3, each of the auxiliary air passageways 7 is provided at a position rotated 90 degrees with respect to the respective air passageways 5 , 6 .
  • the auxiliary air passageway 7 is constructed by axial passages 7 A, 7 A located on the outer periphery of the cylindrical fit hole 2 and extending in the axial direction and opening to the atmosphere at the one axial end face 1 A, and diffusion chamber inflow passages 7 B, 7 B formed as radial passages communicating the respective axial passages 7 A and extending in the radial direction of the medicator body 1 and opening to the medical powder diffusion chamber 4 .
  • Each of the auxiliary air passageways 7 functions to avoid difficulty in breathing action by increasing a quantity of air flowing through the medicator during breathing action, and to strengthen the whirling flow within the medical powder diffusion chamber 4 .
  • the diffusion chamber inflow passage 7 B of the auxiliary air passageway 7 opening to the medical powder diffusion chamber 4 is formed so that its tip end portion opens at an eccentric position in which the inflow passage extends in the tangential direction of the medical powder diffusion chamber 4 , thus producing the whirling flow within the medical powder diffusion chamber 4 by way of air flow flowing into the medical powder diffusion chamber 4 .
  • the whirling flow can finely atomize a lump of granular or powdered medicines 16 adhered to each other due to aggregation, condensation or the like.
  • a portion denoted by reference sign 8 is a medical powder storage cylindrical member rotatably installed at the opening end of the cylindrical fit hole 2 .
  • the medical powder storage cylindrical member 8 is mainly constructed by a cylindrical portion 9 inserted and fitted into the cylindrical fit hole 2 , and a disc-shaped knob portion 10 provided at the base portion of the cylindrical portion 9 .
  • the interior of the cylindrical portion 9 is formed as a medical powder storage hole 11 having a bottom and opening towards its tip end.
  • the above medical powder storage hole 11 defines a medical powder storage chamber 12 capable of storing the medical powder 16 between the storage hole and the bottom portion 2 A of the cylindrical fit hole 2 by way of fit of the cylindrical portion 9 into the cylindrical fit hole 2 of the medicator body 1 .
  • the previously-noted cylindrical portion 9 is formed at its tip end portion with an annular protruded portion 9 A which is fitted into the annular recessed groove 2 B of the cylindrical fit hole 2 . Fitted engagement between the annular recessed groove 2 B and the annular protruded portion 9 A prevents from the medical powder storage cylindrical member 8 from being fallen out.
  • the cylindrical portion 9 is formed at a position corresponding to the radial passage 5 B of the inflow air passageway 5 in the axial direction with an inflow outlet port 9 B so that the inflow outlet port extends or penetrates in the radial direction, and is also formed at a position corresponding to the radial passage 6 A of the outflow air passageway 6 in the axial direction with an outflow outlet port 9 C so that the outflow outlet port extends or penetrates in the radial direction.
  • the knob portion 10 is abutted-engagement with the one axial end face 1 A of the medicator body 1 in a powder-tight fashion.
  • the knob portion is formed on its outer periphery with a knurling portion 10 A serving as a non-slip portion during rotary motion of the medical powder storage cylindrical member 8 .
  • the knob portion 10 is formed with atmospheric outlet portions 10 B, 10 B, . . .
  • the medical powder storage cylindrical member 8 closes the medical powder storage chamber 12 by rotating the cylindrical portion 9 relative to the medicator body 1 while grasping the knob portion 10 and therefore moving the air passageways 5 and 6 and the outlet ports 9 B and 9 C in the circumferential direction, with the result that the medical powder storage chamber 12 is fully closed.
  • the air passageways 5 and 6 are opened to the medical powder storage chamber, with the result that inhalation action of the medical powders can be allowed.
  • the atmospheric outlet ports l 0 B formed in the knob portion 10 act to open or close the air passageways 5 and 7 . Therefore, under a condition where the air passageways 5 and 7 are closed by means of the knob portion 10 , it is possible to prevent dusts from flowing from the outside into the air passageways 5 and 7 .
  • a portion denoted by 13 is a stopper mechanism serving as a stopper means provided between the medicator body 1 and the medical powder storage cylindrical member 8 .
  • the stopper mechanism 13 is constructed by a positioning groove 14 formed in the outer periphery of the medicator body 1 and a protruded portion 15 located on the outer periphery of the knob portion 10 of the medical powder cylindrical member 8 and projected toward the positioning groove 14 .
  • the positioning groove 14 is formed with a closed-position recessed portion 14 A which is brought into engagement with the protruded portion 15 at the closed position (see FIG.
  • the stopper mechanism 13 permits the air passageways 5 , 6 and 7 to be easily rapidly communicated with the respective outlet ports 9 B, 9 C and 10 B with the rotary action of the medical powder storage cylindrical member 8 relative to the medicator body 1 .
  • Reference sign 16 denotes medical powder stored in the cylindrical fit hole 2 .
  • the medical powder 16 is formed as powdered or granulated medicines.
  • the medical powder 16 is charged into the medical powder storage chamber 12 at a stage where the medical powder storage cylindrical member 8 is installed on the medicator body 1 .
  • the inhalant medicator of the embodiment is constructed as previously discussed. Hereinbelow described in detail are the operation of the inhalant medication through which the patient inhales the medical powder, and the flow of air and medical powder during inhalation.
  • the medical powder 16 finely atomized within the medical powder diffusion chamber 4 , is discharged into the inhalant port 3 .
  • the inhalant medicator can be constructed by two component parts, namely the medicator body 1 and the medical powder storage cylindrical member 8 , thus reducing the number of component parts, and ensuring more simplified inhalator structure and reduced production costs, in comparison with the conventional inhalant medicator.
  • the inhalant medicator of the embodiment can be used as a throwaway type.
  • the medical powder diffusion chamber 4 is provided between the cylindrical fit hole 2 and the inhalant port 3 . Therefore, it is possible to certainly finely atomize the medical powder 16 . This ensures an enhanced inhalation efficiency of medical powder 16 and an enhanced reliability of the inhalant medicator. Additionally, it is possible to produce whirling flow within the medical powder diffusion chamber 4 , thus more finely atomizing medical powder 16 .
  • the stopper mechanism 13 is provided between the medicator body 1 and the medical powder storage cylindrical member 8 , for positioning the medical powder storage cylindrical member at either a closed position for prevention of loss of flow of medical powder 16 and an open position for medication, with rotary operation of the medical powder storage cylindrical member 8 . Therefore, a series of operations for medication can be easily certainly achieved.
  • FIG. 8 Hereunder described in reference to FIG. 8 is the second embodiment of the invention.
  • the auxiliary air passageways used in the first embodiment are eliminated, and in lieu thereof the inflow and outflow air passageways are increased.
  • the same reference signs used to designate elements in the first embodiment will be applied to the corresponding elements used in the second embodiment, and detailed description of the same elements will be omitted because the above description thereon seems to be self-explanatory.
  • a portion denoted by reference sign 21 is a medicator body of the second embodiment.
  • Portions denoted by reference signs 22 , 22 . . . are inflow air passageways formed in the medicator body 21 .
  • each of the inflow air passageways 22 is constructed by an axial passage 22 A and a radial passage 22 B.
  • the inflow air passageway 22 of the second embodiment is different from the inflow air passageway 5 of the first embodiment, in that four passageways (only three passageways are shown in the drawing) spaced from each other in the circumferential direction are provided.
  • each of the outflow air passageways 23 is constructed by a radial passage 23 A, an axial passage 23 B, and a diffusion chamber inflow passage 23 C.
  • the outflow air passageway 23 of the second embodiment is different from the outflow air passageway 6 of the first embodiment, in that four passageways (only three passageways are shown in the drawing) spaced from each other in the circumferential direction are provided.
  • the second embodiment as constructed above can provide the same effects and operation as the first embodiment.
  • the auxiliary air passageways 7 used in the first embodiment are eliminated, and in lieu thereof the four inflow air passageways 22 are provided, thus ensuring increased air flow of air flowing into the medical powder storage chamber 12 .
  • the increased air flow can effectively atomize the medical powder 16 .
  • the third embodiment is characterized in that a second medical powder diffusion chamber is provided between the cylindrical fit hole and the medical powder diffusion chamber.
  • the same reference signs used to designate elements in the first embodiment will be applied to the corresponding elements used in the third embodiment, and detailed description of the same elements will be omitted because the above description thereon seems to be self-explanatory.
  • a portion denoted by reference sign 31 is a medicator body of the third embodiment. Substantially in the same manner as the medicator body 1 of the first embodiment, the medicator body 31 is formed therein with a cylindrical fit hole 32 , an inhalant port 33 , and others. However, the medicator body 31 of the third embodiment has a first medical powder diffusion chamber 34 and a second medical powder diffusion chamber 35 , both provided between the cylindrical fit hole 32 and the inhalant port 33 . The medicator body of the third embodiment is different from the medicator body 1 of the first embodiment, in that as a whole the medicator body of the third embodiment is formed as a longer body.
  • each of the inflow air passageways 36 is constructed by an axial passage 36 A and a radial passage 36 B.
  • Portions denoted by reference signs 37 , 37 . . . are two first outflow air passageways.
  • Each of the first outflow air passageways 37 is constructed by radial passages 37 A, 37 A extending in the radial direction and opening to the cylindrical fit hole 32 , axial passages 37 B, 37 B, communicating the respective tip end portions of the radial passages 37 A and extending in the axial direction, and diffusion chamber inflow passages 37 C, 37 C formed as radial passages extending in the radial direction from the respective tip end portions of the axial passages 37 B and opening to the first medical powder diffusion chamber 34 .
  • Portions denoted by reference signs 38 , 38 . . . are four second outflow air passageways of the third embodiment.
  • Each of the second outflow air passageways 38 is constructed by diffusion chamber outflow passages 38 A, 38 A formed as radial passages extending in the radial direction and opening to the first medical powder diffusion chamber 34 , axial passages 38 B, 38 B communicating the respective tip end portions of the diffusion chamber outflow passages 38 A and extending in the axial direction, and diffusion chamber inflow passages 38 C, 38 C formed as radial passages extending in the radial direction from the tip end portions of the axial passages 38 B and opening to the second medical powder diffusion chamber 35 .
  • auxiliary air passageways 39 are two auxiliary air passageways of the third embodiment.
  • Each of the auxiliary air passageways 39 is constructed by axial passages 39 A, 39 A, and diffusion chamber inflow passages 39 B, 39 B formed as radial passages communicating the respective axial passages 39 A and extending in the radial direction and opening to the first medical powder diffusion chamber 34 .
  • the diffusion chamber inflow passage 37 C of the first inflow air passageway 37 opening to the first medical powder diffusion chamber 34 and the diffusion chamber inflow passage 39 B of the auxiliary air passageway 39 are configured so that their tip end portions open at an eccentric position in which the inflow passage extends in the tangential direction of the first medical powder diffusion chamber 34 .
  • the diffusion chamber outflow passage 38 A of the second inflow air passageway 38 opening to the first medical powder diffusion chamber 34 is configured, so that its tip end portion opens at an eccentric position in which the outflow passage extends in the tangential direction opposite to the diffusion chamber inflow passage 39 B of the auxiliary air passageway 39 , in order to facilitate the whirling flow produced within the first medical powder diffusion chamber 34 and passing through the diffusion chamber outflow passage 38 A.
  • the diffusion chamber inflow passage 38 C of the second outflow air passageway 38 opening to the second medical powder diffusion chamber 35 opens at an eccentric position in which the inflow passage extends in the same tangential direction as the diffusion chamber inflow passage 37 C of the first outflow air passageway 37 and the diffusion chamber inflow passage 39 B of the auxiliary air passageway 39 .
  • the third embodiment as constructed above, can provide the same effects and operation as the first embodiment.
  • two medical powder diffusion chambers namely the first and second medical powder diffusion chambers 34 and 35 are provided.
  • the medical powder 16 includes granulated medicines having a strong condensation property and the granulated medicines are adhered to each other to form a lump of granulated medicines, as can be seen from FIG. 12, it is possible to break and atomize the lump of medical powder by means of the two medical powder diffusion chambers 34 and 35 . As a consequence, it is possible to inhale a specified amount of medical powder into lungs of the patient.
  • a medical powder storage cylindrical member is constructed by a cylindrical portion axially slidably fitted into the inner peripheral surface of the cylindrical fit hole, a knob portion provided at the cylindrical portion and capable of taking out or putting in with respect to the medicator body, and inflow and outflow outlet ports through which the inflow and outflow air passageways are opened or closed by way of taking-out or putting-in operation of the knob portion.
  • the same reference signs used to designate elements in the first embodiment will be applied to the corresponding elements used in the fourth embodiment, and detailed description of the same elements will be omitted because the above description thereon seems to be self-explanatory.
  • a portion denoted by reference sign 41 is a medicator body of the fourth embodiment.
  • a portion denoted by reference sign 42 is a cylindrical fit hole formed in the medicator body 41 .
  • the cylindrical fit hole 42 has an axially extending bore opening at one axial end 41 A and having a circular shape in cross section and having a bottom.
  • the bottom portion 42 A of the cylindrical fit hole is formed as a spherical surface.
  • the bottom portion 42 A of the cylindrical fit hole 42 is formed with a C-shaped groove 42 B. As shown in FIG. 14, the C-shaped groove 42 B is configured in such a manner as to guide movably an engaged protruded portion 44 A of a cylindrical portion 44 described later.
  • a portion denoted by reference sign 43 is a medical powder storage cylindrical member of the fourth embodiment, installed on the cylindrical fit hole 42 so that the medical powder storage cylindrical member is capable of taking out or putting in with respect to the opening end of the cylindrical fit hole 42 .
  • the medical powder storage cylindrical member 43 is mainly constructed by a cylindrical portion 44 inserted and fitted into the cylindrical fit hole 42 , and a disc-shaped knob portion 45 provided at the base portion of the cylindrical portion 44 .
  • the interior of the cylindrical portion 44 is formed as a medical powder storage hole 46 .
  • a medical powder storage chamber 47 is defined between the medical powder storage hole 46 and the bottom portion 42 A of the cylindrical fit hole 42 .
  • the medical powder storage cylindrical member 43 of the fourth embodiment is different from the medical powder storage cylindrical member 43 of the first embodiment, in that the engaged protruded portion 4 A, fitted to the C-shaped groove 42 B of the cylindrical fit hole 42 , is provided at the tip end portion of the cylindrical portion 44 , inflow outlet port 44 B and outflow outlet port 44 C are formed in the cylindrical portion 44 at positions at which the inflow and outflow outlet ports respectively communicate the radial passage 5 B of the inflow air passageway 5 and the radial passage 6 A of the outflow air passageway 6 under a condition where the cylindrical portion 44 is extracted, and the atmospheric outlet ports used in the first embodiment are removed from the knob portion 45 .
  • the C-shaped groove 42 B formed in the cylindrical fit hole 42 of the medicator body 41 and the engaged protruded portion 44 A formed in the cylindrical portion 44 of the medical powder storage cylindrical member 43 cooperate to each other to construct a stopper mechanism 48 serving as a stopper means for positioning the medical powder storage cylindrical member 43 during taking-out/putting-in operation of the medical powder storage cylindrical member 43 with respect to the medicator body 41 .
  • the inhalant medicator of the fourth embodiment is constructed as previously discussed. Hereinbelow described in detail is the operation of the inhalant medication through which the patient inhales the medical powder.
  • the medical powder storage cylindrical member 43 is rotated relative to the medicator body 41 in the direction indicated by the arrow A shown in FIGS. 13 and 14.
  • the cylindrical portion 44 of the medical powder storage cylindrical member 43 is extracted in the direction indicated by the arrow B.
  • the medical powder storage cylindrical member 43 returns the medical powder storage cylindrical member 43 to the direction indicated by the arrow C, as shown in FIG. 15, it is possible to position in such a manner as to establish fluid communication between the air passageway 5 and the inflow outlet port 44 B and fluid communication between the air passageway 6 and the outflow outlet port 44 C.
  • the medical powder 16 can be inhaled.
  • the fourth embodiment as constructed above, can provide the same effects and operation as the first embodiment.
  • the auxiliary air passageways 39 , 39 through which the first medical powder diffusion chamber is communicated with the atmospheric side is formed in the medicator body 31 .
  • the present invention is not limited to the particular embodiments shown and described herein.
  • another auxiliary air passageways 39 , 39 (only one passageway is shown in the drawing) intercommunicating the atmospheric side and the second medical powder diffusion chamber 35 , may be formed in the medicator body 31 , independently of the auxiliary air passageways 39 , 39 intercommunicating the atmospheric side and the first medical powder diffusion chamber 34 .
  • the inflow air passageway 5 is constructed by the axial passage 5 A and the radial passage 5 B.
  • an inflow air passageway 5 ′ is formed so that the inflow air passageway extends in the radial direction and opens to a curved surface of the medicator body 1 .
  • such a construction can be applied to the other embodiments.
  • one medical powder diffusion chamber 4 is provided, whereas in the second embodiment and the modification two medical powder diffusion chambers 34 , 35 are provided.
  • the invention is not limited to the particular embodiments shown and described herein.
  • three or more medical powder diffusion chambers may be provided. It is preferable that the number of the medical powder diffusion chambers is determined or set depending on characteristics or properties of medical powder (such as a condensation property).
  • the medical powder 16 is encapsulated within the cylindrical fit hole 2 at a time when the medicator body 1 and the medical powder storage cylindrical member 8 are assembled to each other.
  • the medical powder 16 may be charged into the cylindrical fit hole 2 just before the operation of inhalant medication. In the same manner, such a construction can be applied to the other embodiments.
  • the opening and closing of the inflow air passageways 5 , 22 , 36 with respect to the atmospheric side are made by the respective knob portions 10 , 45 of the medical powder storage cylindrical members 8 , 43 .
  • the invention is not limited to the particular embodiments shown and described herein.
  • the knob portion is configured to have the same diameter dimension as the cylindrical portion. That is, it is unnecessary to always close the atmospheric outlet port of the inflow air passageway.
  • the inflow air passageways 5 , 22 , 36 and the outflow air passageways 6 , 23 , 37 are formed so that these passageways extend in the radial direction towards the central portion of the cylindrical fit holes 2 , 32 , 42 .
  • these air passageways may be constructed so that the air passageways open to the respective cylindrical fit holes at eccentric positions in which the air passageways extend in the respective tangential directions of the cylindrical fit holes.
  • the medical powder storage chamber 12 is defined between the bottom portion 2 A of the cylindrical fit hole 2 and the medical powder storage hole 11 by fitting the cylindrical portion 9 of the medical powder storage member 8 into the cylindrical fit hole 2 of the medicator body 1 .
  • a medical powder storage hole 54 may be provided by defining the medical powder storage chamber by way of only a cylindrical portion 52 of a medical powder storage cylindrical member 51 .
  • the bottom face of the cylindrical fit hole of the medicator body is designed to be flat. In the same manner, such a construction can be applied to the other embodiments.
  • the medical powder in the cylindrical fit hole can be atomized.
  • the mixture of the incoming air and medical powder passes through the outflow air passageway and then flows towards within the inhalant port, and thus the patient can inhale the medical powder through the inhalant port into lungs of the patient.
  • the inhalant medicator of the invention is constructed by two component parts, namely the medicator body and the medical powder storage cylindrical member, and also it is possible to open and close each of the air passageways with respect to the medical powder storage hole by means of the medical powder storage cylindrical member, thereby reducing production costs, and consequently ensuring reduced economical burden of the patient.
  • the inhalant medicator of the invention can be suitably used as a throwaway type.
  • the patient can inhale a specified amount of medical powder into lungs. This enhances medical benefits of the powdered or granular medicines, and also enhances the reliability of the inhalant medicator.
  • the inflow and outflow air passageways can be respectively opened or closed by means of the inflow outlet port and the outflow outlet port by rotating the medical powder storage cylindrical member relative to the medicator body while grasping the knob portion.
  • the inflow air passageway and the outflow air passageway are respectively closed by the inflow outlet port and the outflow outlet port, it is possible to prevent the medical powder to flow out.
  • the inflow and outflow air passageways can be respectively opened or closed through the inflow outlet port and the outflow outlet port by taking out or putting in the medical powder storage cylindrical member relative to the medicator body, while grasping the knob portion.
  • the inflow air passageway and the outflow air passageway are respectively closed by the inflow outlet port and the outflow outlet port, it is possible to prevent the medical powder to flow out.
  • the stopper means when operating the medical powder storage cylindrical member, can position the medical powder storage cylindrical member at the position where the inflow outlet port and the inflow air passageway are communicated with each other and the outflow outlet port and the outflow air passageway are communicated with each other.
  • the stopper means can position the medical powder storage cylindrical member at the position where the inflow outlet port and the inflow air passageway are communicated with each other and the outflow outlet port and the outflow air passageway are communicated with each other.

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Anesthesiology (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Nozzles (AREA)

Abstract

An inhalant medicator includes a medicator body 1 which is formed therein with a cylindrical fit hole 2, an inhalant port 3, an inflow air passageway 5, and an outflow air passageway 6, and a medical powder storage cylindrical member 8 which is installed or fitted into the cylindrical fit hole 2 in a manner so as to open or close the air passageways 5 and 6 with respect to a medical powder storage chamber 12. The inhalant medicator is constructed by two component parts, namely the medicator body 1 and the medical powder storage cylindrical member 8, thus ensuring simplified structure and reduced production costs. Additionally, powder-and-granular medicine or medical powder 16 is tightly encapsulated within the medical powder storage chamber 12 by means of the medical powder storage cylindrical member 8, thus preventing loss of flow of the medical powder 16.

Description

    TECHNICAL FIELD
  • The invention relates to an inhalant medicator suitable to prescribe granular or powdered medicines (medical powder) toward within lungs of a patient by way of breathing action of the patient. [0001]
  • BACKGROUND ART
  • Generally, there are two medications of prescribing a medicine toward within lungs of an asthmatic patient, that is, one being a medication that a medicine is inhaled by way of a liquid aerosol atomizer, and the other being an inhalation treatment that granular or powdered medicines (which will be hereinafter referred to as “medical powder”) encapsulated in a capsule are inhaled. [0002]
  • Of these medications for an asthmatic patient, an inhalant medicator used for an inhalation treatment where encapsulated medical powder is inhaled, has been disclosed in Japanese Patent Provisional Publication No. 7-313599. [0003]
  • The inhalant medicator as disclosed in the above Japanese Patent Provisional Publication is generally comprised of a medicator body equipped at one axial end with a capsule housing hole and at the other axial end with an inhalant port, an inflow air passageway formed in the medicator body for flowing air into the capsule housing hole, an outflow air passageway formed in the medicator body for flowing medical powder stored in the capsule of the capsule housing hole together with airflown through the inflow air passageway into the inhalant port, pin insertion holes located at both sides of the capsule housing hole in the axial directions of the capsule housing hole and bored in the medicator body in such a manner as to extend in a radial direction of the medicator body for communicating each of the inflow and outflow air passageways, and a boring tool having pins insertable toward the capsule through the respective pin insertion holes for breaking through the capsule accommodated in the capsule housing hole. [0004]
  • In such inhalant medicators, the capsule is accommodated in the capsule housing hole, and holes, communicating the internal space of the capsule with each of the air passageways, are pricked or punched by means of the boring tool. Under this condition, the patient draws his or her breath while taking the inhalant port in his or her mouse, and thus air is flown from the atmospheric side through the inflow air passageway into the capsule. The air flow carries and discharges the medical powder stored in the capsule through the outflow air passageway into the inhalant port. In this manner, the medical powder flowing out of the capsule can be inhaled through the inhalant port into the lungs of the patient. [0005]
  • The conventional inhalant medicator described above, is constructed so that a capsule is inserted into a capsule housing hole of a medicator body, and the medical powder stored in the capsule is inhaled by pricking or punching holes in the capsules by way of a boring tool. For the reasons set forth above, there is the necessity for pin insertion holes and the boring tool. This increases the number of component parts, and induces a complicated structure. Thus, there are some problems, such as increased production costs and increased economical burden of a patient. [0006]
  • Also, in recent years, there are another problems, such as sanitary problems and a throwaway type of medicators. In particular, in case of a pose of medicine to be taken only once, a medicator is not used continuously. In this case, a new medicator is used only once for each medication. A so-called throwaway type of medicators exists. Therefore, people can think about the use of the conventional medicator as a throwaway type. However, for the reasons set out above, this medicator is not suitable to use as a throwaway type. [0007]
  • DISCLOSURE OF THE INVENTION
  • It is, therefore, in view of the previously-described disadvantages of the prior art, an object of the present invention to provide an inhalant medicator which is capable of reducing production costs by reducing the number of component parts and by simplifying its structure. [0008]
  • In order to accomplish the aforementioned and other objects, according to the invention as claimed in [0009] claim 1, an inhalant medicator comprises a medicator body formed with a cylindrical fit hole opening at one axial end and formed at the other axial end with an inhalant port, an inflow air passageway formed in the medicator body for supplying air into the cylindrical fit hole, an outflow air passageway formed in the medicator body for discharging air from the cylindrical fit hole into the inhalant port, and a medical powder storage cylindrical member having a cylindrical portion defining therein a medical powder storage hole whose internal space stores a medical powder and capable of opening and closing each of the inflow air passageway and the outflow air passageway with respect to the medical powder storage hole by external operation.
  • In the inhalant medicator as constructed above, under a condition where the inflow air passageway and the outflow air passageway are closed with respect to the medical powder storage hole by means of the medical powder storage cylindrical member, it is possible to prevent the medical powder stored in the medical powder storage hole from flowing to the outside via the air passageways. On the other hand, when the medical powder has to be inhaled, the inflow air passageway and the outflow air passageway are communicated with the medical powder storage hole by operating the medical powder storage cylindrical member. Under these conditions, the patient draws his or her breath while taking the inhalant port in his or her mouse, atmosphere flown into the inflow air passageway flows into the medical powder storage hole, taking the form of air flow. As a result of this, the medical powder in the medical powder storage hole can be atomized. Thus, in a blended condition of the medical powder with air flow, the mixture of the incoming air and medical powder passes through the outflow air passageway and then flows towards within the inhalant port, and then the mixture is inhaled through the inhalant port into lungs of the patient. [0010]
  • The inhalant medicator of the invention is constructed by two component parts, namely the medicator body and the medical powder storage cylindrical member, and also it is possible to open and close each of the air passageways with respect to the medical powder storage hole by means of the medical powder storage cylindrical member, thus ensuring a simple structure of the medicator. This reduces production costs. Additionally, even when the medical powder storage hole is filled with granular or powdered medicines in advance, it is possible to prevent the medical powder stored in the medical powder storage hole from flowing to the outside. [0011]
  • According to the invention as claimed in [0012] claim 2, at least one medical powder diffusion chamber is formed in the medicator body and located between the cylindrical fit hole and the inhalant port for diffusing the medical powder flowing out of the outflow air passageway.
  • In the inhalant medicator as constructed above, when the patient draws his or her breath while taking the inhalant port in his or her mouse, the medical powder flowing from the medical powder storage hole via the outflow air passageway can be further diffused through the medical powder diffusion chamber, and thus the medical powder can flow into the inhalant port in a finely atomized fashion. [0013]
  • According to the invention as claimed in [0014] claim 3, the air passageway communicating with the medical powder diffusion chamber is formed to open to the medical powder diffusion chamber at an eccentric position in which the air passageway extends in a tangential direction of the medical powder diffusion chamber.
  • In the inhalant medicator as constructed above, when air flow passes through the inflow air passageway and then flows into the medical powder diffusion chamber, the inflow air passageway eccentrically arranged in the tangential direction of the medical powder diffusion chamber produces whirling flow within the medical powder diffusion chamber. Thus, even when granulated medicines; having a strong condensation property or a bad dispersion, are adhered or stuck to each other, it is possible to atomize the granulated medicines by virtue of the whirling flow. [0015]
  • According to the invention as claimed in [0016] claim 4, the medical powder storage cylindrical member is constructed by a cylindrical portion rotatably fitted into the inner peripheral wall of the cylindrical fit hole and a knob portion provided at the cylindrical portion and operated rotatably with respect to the medicator body, and inflow and outflow outlet ports through which the inflow and outflow air passageways are opened or closed by way of rotary operation of the knob portion.
  • In the inhalant medicator as constructed above, the inflow and outflow air passageways can be respectively opened or closed by means of the inflow outlet port and the outflow outlet port by rotating the medical powder storage cylindrical member relative to the medicator body while grasping the knob portion. [0017]
  • According to the invention as claimed in [0018] claim 5, the medical powder storage cylindrical member is constructed by a cylindrical portion axially slidably fitted into the inner peripheral wall of the cylindrical fit hole, a knob portion provided at the cylindrical portion and capable of taking out or putting in with respect to the medicator body, and inflow and outflow outlet ports through which the inflow and outflow air passageways are opened or closed by way of taking-out or putting-in operation of the knob portion.
  • In the inhalant medicator as constructed above, the inflow and outflow air passageways can be respectively opened or closed through the inflow outlet port and the outflow outlet port by taking out or putting in the medical powder storage cylindrical member relative to the medicator body, while grasping the knob portion. [0019]
  • According to the invention as claimed in [0020] claim 6,a stopper means is provided between the medicator body and the medical powder storage cylindrical member for positioning the medical powder storage cylindrical member at a position where the inflow outlet port is communicated with the inflow air passageway and the outflow outlet port is communicated with the outflow air passageway when operating the medical powder storage cylindrical member.
  • In the inhalant medicator as constructed above, when operating the medical powder storage cylindrical member, the stopper means can position the medical powder storage cylindrical member at the position where the inflow outlet port and the inflow air passageway are communicated with each other and the outflow outlet port and the outflow air passageway are communicated with each other. Thus, it is possible to easily and certainly open or close the inflow and outflow air passageways.[0021]
  • BRIEF DESCRIPTION OF THE DRAWINGS
  • FIG. 1 is a longitudinal cross-sectional view illustrating a first embodiment of an inhalant medicator made according to the invention. [0022]
  • FIG. 2 is an enlarged lateral cross-sectional view illustrating a medicator body, a cylindrical portion, an inflow air passageway (an outflow air passageway), and others as viewed from the arrow indicated by II-II shown in FIG. 1. [0023]
  • FIG. 3 is an enlarged lateral cross-sectional view illustrating a medicator body, an outflow air passageway, and others as viewed from the arrow indicated by III-III shown in FIG. 1. [0024]
  • FIG. 4 is an enlarged perspective view illustrating the appearance of a medical powder storage cylindrical member. [0025]
  • FIG. 5 is an enlarged perspective view illustrating an essential part of a stopper mechanism provided at the medicator body and the knob portion of the medical powder storage cylindrical member. [0026]
  • FIG. 6 is an enlarged lateral cross-sectional view illustrating a state of the air passageway formed in the medicator body and the outlet port formed in the cylindrical portion of the medical powder storage cylindrical member, spaced to each other in the circumferential direction, as viewed from the same position as FIG. 2. [0027]
  • FIG. 7 is a longitudinal cross-sectional view illustrating the inhalant medicator under a particular condition in which medical powders are inhaled, as viewed from the same position as FIG. 1. [0028]
  • FIG. 8 is a longitudinal cross-sectional view illustrating a second embodiment of an inhalant medicator made according to the invention. [0029]
  • FIG. 9 is a longitudinal cross-sectional view illustrating a third embodiment of an inhalant medicator made according to the invention. [0030]
  • FIG. 10 is an enlarged lateral cross-sectional view illustrating the medicator body, a first outflow air passageway and others, as viewed from the arrow indicated by X-X shown in FIG. 9. [0031]
  • FIG. 11 is an enlarged lateral cross-sectional view illustrating the medicator body, a second outflow air passageway and others, as viewed from the arrow indicated by XI-XI shown in FIG. 9. [0032]
  • FIG. 12 is a longitudinal cross-sectional view illustrating the inhalant medicator under a particular condition in which a medical powder is inhaled, as viewed from the same position as FIG. 9. [0033]
  • FIG. 13 is a longitudinal cross-sectional view illustrating a fourth embodiment of an inhalant medicator made according to the invention. [0034]
  • FIG. 14 is an enlarged cross-sectional view illustrating an essential part of the inhalant medicator in an engaged state between a C-shaped groove of the cylindrical fit hole and an engaged protruded portion of the medical powder storage cylindrical member, as viewed from the arrow indicated by XIV-XIV shown in FIG. 9. [0035]
  • FIG. 15 is a longitudinal cross-sectional view illustrating the inhalant medicator in an inhalation state of medical powder with the medical powder storage cylindrical member extracted from the medicator body, as viewed from the same position as FIG. 13. [0036]
  • FIG. 16 is a longitudinal cross-sectional view illustrating an inhalant medicator corresponding to a first modification of the invention. [0037]
  • FIG. 17 is a longitudinal cross-sectional view illustrating only a medical powder storage cylindrical member corresponding to a second modification of the invention.[0038]
  • DESCRIPTION OF THE PREFERRED EMBODIMENTS
  • The embodiments of the inhalant medicator of the present invention will be hereinbelow described in detail in reference to the drawings attached hereto. [0039]
  • Referring now to FIGS. 1 through 7, there is shown the first embodiment of the invention. [0040] Reference sign 1 denotes a cylindrical medicator body constructing an essential part of the inhalant medicator. The medicator body 1 is formed with a cylindrical fit hole 2 as described later, an inhalant port 3, an inflow air passageway 5, an outflow air passageway 6, and others.
  • A portion denoted by [0041] reference sign 2 is the cylindrical fit hole formed in the medicator body 1 at one axial end. The cylindrical fit hole 2 has an axially extending bore opening at the one axial end face 1A and having a circular shape in cross section and having a bottom. The bottom portion 2A of the cylindrical fit hole is formed as a spherical surface. Also, the bottom portion 2A of the cylindrical fit hole 2 is formed with an annular recessed groove 2B. The annular recessed groove 2B is configured so that an annular protruded portion 9A formed at the tip end portion of a cylindrical portion 9 of a medical powder storage cylindrical member 8, which will be described later.
  • A portion denoted by [0042] reference sign 3 is the inhalant port formed at the other axial end of the medicator body 1. The inhalant port 3 is formed and configured in such a manner as to gradually diametrically enlarged in the other axial direction. Additionally, the inner part of the inhalant port 3 is formed with a medical powder diffusion chamber 4, which will be described later.
  • A portion denoted by [0043] reference sign 4 is the medical powder diffusion chamber located between the cylindrical fit hole 2 and the inhalant port 3 and formed in the medicator body 1. The medical powder diffusion chamber 4 is formed as a cylindrical space axially extending toward the inhalant port 3, so that whirling flow is produced by way of air flow of air flowing through the inflow air passageway which will be described later.
  • Portions denoted by [0044] reference signs 5, 5 are two inflow air passageways formed in one axial end of the medicator body 1. As shown in FIGS. 1 and 2, each of the inflow air passageways 5 is constructed by axially-extending axial passages 5A, SA located on the outer periphery of the cylindrical fit hole 2 and opening to the atmosphere at the one axial end face 1A, and radial passages 5B, 5B communicating the respective axial passages 5A and extending in the radial direction of the medicator body 1 and opening to the cylindrical fit bore 2.
  • Portions denoted by [0045] reference signs 6, 6 are two outflow air passageways formed in a substantially middle portion of the medicator body 1 (as viewed from the axial direction of the medicator body). Each of the outflow air passageways 6 is constructed by radial air passageways 6A, 6A extending in the radial direction of the medicator body 1 and opening to the cylindrical fit hole 2, and axial passages 6B, 6B communicating the respective tip end portions of the radial passages 6A and extending in two opposite axial directions, and diffusion chamber inflow passages 6C, 6C formed as radial passages extending radially from the respective tip end portions of the axial passages 6B and opening to the diffusion chamber 4.
  • The diffusion [0046] chamber inflow passage 6C of the inflow air passageway 6, opening to the medical powder diffusion chamber 4, is formed so that its tip end portion opens at an eccentric position in which the inflow passage extends in the tangential direction of the medical powder diffusion chamber 4. As a result of this, air flow flowing through the diffusion chamber inflow passage 6C into the medical powder diffusion chamber 4 becomes changed or converted into whirling flow, thus finely atomizing a lump of granular or powdered medicines 16 adhered to each other due to aggregation, condensation or the like.
  • Portions denoted by [0047] reference signs 7, 7 are two auxiliary air passageways located on the outer periphery of the cylindrical fit hole 2 and formed in the medicator body 1. As shown in FIG. 3, each of the auxiliary air passageways 7 is provided at a position rotated 90 degrees with respect to the respective air passageways 5, 6. The auxiliary air passageway 7 is constructed by axial passages 7A, 7A located on the outer periphery of the cylindrical fit hole 2 and extending in the axial direction and opening to the atmosphere at the one axial end face 1A, and diffusion chamber inflow passages 7B, 7B formed as radial passages communicating the respective axial passages 7A and extending in the radial direction of the medicator body 1 and opening to the medical powder diffusion chamber 4. Each of the auxiliary air passageways 7 functions to avoid difficulty in breathing action by increasing a quantity of air flowing through the medicator during breathing action, and to strengthen the whirling flow within the medical powder diffusion chamber 4.
  • Hereupon, in the same manner as the diffusion [0048] chamber inflow passage 6C of the outflow air passageway 6 described previously, the diffusion chamber inflow passage 7B of the auxiliary air passageway 7 opening to the medical powder diffusion chamber 4 is formed so that its tip end portion opens at an eccentric position in which the inflow passage extends in the tangential direction of the medical powder diffusion chamber 4, thus producing the whirling flow within the medical powder diffusion chamber 4 by way of air flow flowing into the medical powder diffusion chamber 4. The whirling flow can finely atomize a lump of granular or powdered medicines 16 adhered to each other due to aggregation, condensation or the like.
  • Next, a portion denoted by [0049] reference sign 8 is a medical powder storage cylindrical member rotatably installed at the opening end of the cylindrical fit hole 2. As shown in FIG. 4, the medical powder storage cylindrical member 8 is mainly constructed by a cylindrical portion 9 inserted and fitted into the cylindrical fit hole 2, and a disc-shaped knob portion 10 provided at the base portion of the cylindrical portion 9. The interior of the cylindrical portion 9 is formed as a medical powder storage hole 11 having a bottom and opening towards its tip end. Hereupon, the above medical powder storage hole 11 defines a medical powder storage chamber 12 capable of storing the medical powder 16 between the storage hole and the bottom portion 2A of the cylindrical fit hole 2 by way of fit of the cylindrical portion 9 into the cylindrical fit hole 2 of the medicator body 1.
  • Additionally, the previously-noted [0050] cylindrical portion 9 is formed at its tip end portion with an annular protruded portion 9A which is fitted into the annular recessed groove 2B of the cylindrical fit hole 2. Fitted engagement between the annular recessed groove 2B and the annular protruded portion 9A prevents from the medical powder storage cylindrical member 8 from being fallen out. Furthermore, the cylindrical portion 9 is formed at a position corresponding to the radial passage 5B of the inflow air passageway 5 in the axial direction with an inflow outlet port 9B so that the inflow outlet port extends or penetrates in the radial direction, and is also formed at a position corresponding to the radial passage 6A of the outflow air passageway 6 in the axial direction with an outflow outlet port 9C so that the outflow outlet port extends or penetrates in the radial direction.
  • On the other hand, the [0051] knob portion 10 is abutted-engagement with the one axial end face 1A of the medicator body 1 in a powder-tight fashion. As shown in FIGS. 4 and 5, the knob portion is formed on its outer periphery with a knurling portion 10A serving as a non-slip portion during rotary motion of the medical powder storage cylindrical member 8. Also, the knob portion 10 is formed with atmospheric outlet portions 10B, 10B, . . . at positions corresponding to the outlet ports 9B and 9C of the cylindrical portion 9 in the circumferential direction and also corresponding to the axial passage 5A of the inflow air passageway 5 and the axial passage 7A of the auxiliary air passageway 7 in the radial direction, so that the atmospheric outlet portions extend or penetrate in the axial direction.
  • The medical powder storage [0052] cylindrical member 8 closes the medical powder storage chamber 12 by rotating the cylindrical portion 9 relative to the medicator body 1 while grasping the knob portion 10 and therefore moving the air passageways 5 and 6 and the outlet ports 9B and 9C in the circumferential direction, with the result that the medical powder storage chamber 12 is fully closed. On the other hand, by establishing fluid communication between the air passageway 5 and the outlet port 9B and fluid communication between the air passageway 6 and the outlet port 9C, the air passageways 5 and 6 are opened to the medical powder storage chamber, with the result that inhalation action of the medical powders can be allowed.
  • At this time, the atmospheric outlet ports l[0053] 0B formed in the knob portion 10 act to open or close the air passageways 5 and 7. Therefore, under a condition where the air passageways 5 and 7 are closed by means of the knob portion 10, it is possible to prevent dusts from flowing from the outside into the air passageways 5 and 7.
  • A portion denoted by [0054] 13 is a stopper mechanism serving as a stopper means provided between the medicator body 1 and the medical powder storage cylindrical member 8. The stopper mechanism 13 is constructed by a positioning groove 14 formed in the outer periphery of the medicator body 1 and a protruded portion 15 located on the outer periphery of the knob portion 10 of the medical powder cylindrical member 8 and projected toward the positioning groove 14. Also, the positioning groove 14 is formed with a closed-position recessed portion 14A which is brought into engagement with the protruded portion 15 at the closed position (see FIG. 6) at which the inflow air passageway 5 and the inflow outlet port 9B are offset to each other, the outflow air passageway 6 and the outflow outlet port 9C are offset to each other, and the auxiliary air passageway 7 and the atmospheric outlet port 10B are offset to each other, and an open-position recessed portion 14B which is brought into engagement with the protruded portion 15 at the open position (see FIG. 2) where the air passageways 5, 6 and 7 are communicated with the respective outlet ports 9B, 9C. and 10B. As a result of this, the stopper mechanism 13 permits the air passageways 5, 6 and 7 to be easily rapidly communicated with the respective outlet ports 9B, 9C and 10B with the rotary action of the medical powder storage cylindrical member 8 relative to the medicator body 1.
  • [0055] Reference sign 16 denotes medical powder stored in the cylindrical fit hole 2. The medical powder 16 is formed as powdered or granulated medicines. The medical powder 16 is charged into the medical powder storage chamber 12 at a stage where the medical powder storage cylindrical member 8 is installed on the medicator body 1.
  • The inhalant medicator of the embodiment is constructed as previously discussed. Hereinbelow described in detail are the operation of the inhalant medication through which the patient inhales the medical powder, and the flow of air and medical powder during inhalation. [0056]
  • First, rotary operation of the medical powder storage [0057] cylindrical member 8 relative to the medicator body 1 is made, so as to establish fluid communication between the inflow air passageway 5 and the inflow outlet port 9B, fluid communication between the outflow air passageway 6 and the outflow outlet port 9C, and fluid communication between the auxiliary air passageway 7 and the atmospheric outlet port 10B, and thus to ensure the open position.
  • Next, under this condition, the patient draws his or her breath while taking the [0058] inhalant port 3 in his or her mouse. As a result of this, as can be seen from the arrow shown in FIG. 7, air (atmosphere) passes through the atmospheric outlet port 10B of the knob portion 10, the inflow air passageway 5, and the inflow outlet port 9B of the cylindrical portion 9, and then flows into the medical powder storage chamber 12. At this time, air flow flowing into the medical powder storage chamber 12 disperses and atomizes the medical powder 16 stored in the medical powder storage chamber 12.
  • However, there is a lump of [0059] medical powder 16 existing in the internal space. The medical powder 16 passes through the outflow outlet port 9C of the cylindrical portion 9 and the outflow air passageway 6, and then flows into the medical powder diffusion chamber 4. A lump of medical powder 16 can be diffused within the medical powder diffusion chamber 4 by way of whirling flow produced by the diffusion chamber inflow passages 6C and 7B, thus certainly atomizing the medical powder.
  • In this manner, the [0060] medical powder 16, finely atomized within the medical powder diffusion chamber 4, is discharged into the inhalant port 3. Thus, it is possible to prescribe the medical powder via the oral cavity and trachea of a patient into lungs of the patient by inhaling the medical powder discharged via the inhalant port 3 by way of breathing action of the patient.
  • As discussed above, according to the embodiment, the inhalant medicator can be constructed by two component parts, namely the [0061] medicator body 1 and the medical powder storage cylindrical member 8, thus reducing the number of component parts, and ensuring more simplified inhalator structure and reduced production costs, in comparison with the conventional inhalant medicator.
  • Furthermore, it is possible to open or close the [0062] inflow air passageway 5 and the outflow air passageway 6 with respect to the medical powder storage chamber 12 by means of the medical powder storage cylindrical member 8. Thus, it is possible to tightly encapsulate the medical powder 16 within the medical powder storage chamber 12, thus preventing undesirable loss of flow of medical powder 16.
  • As appreciated from the above, even when the inhalant medicator of the embodiment is thrown away after the inhalant medicator has been used only once, it is possible to reduce an economical burden of the patient. Additionally, even when the medical [0063] powder storage chamber 12 is filled with medical powder 16 during assembling process, it is possible to prevent undesirable loss of flow of medical powders 16. Thus, the inhalant medicator of the embodiment can be used as a throwaway type.
  • On the one hand, the medical [0064] powder diffusion chamber 4 is provided between the cylindrical fit hole 2 and the inhalant port 3. Therefore, it is possible to certainly finely atomize the medical powder 16. This ensures an enhanced inhalation efficiency of medical powder 16 and an enhanced reliability of the inhalant medicator. Additionally, it is possible to produce whirling flow within the medical powder diffusion chamber 4, thus more finely atomizing medical powder 16.
  • Moreover, the [0065] stopper mechanism 13 is provided between the medicator body 1 and the medical powder storage cylindrical member 8, for positioning the medical powder storage cylindrical member at either a closed position for prevention of loss of flow of medical powder 16 and an open position for medication, with rotary operation of the medical powder storage cylindrical member 8. Therefore, a series of operations for medication can be easily certainly achieved. Everyone can easily handle the inhalant medicator of the embodiment.
  • Hereunder described in reference to FIG. 8 is the second embodiment of the invention. In the second embodiment, the auxiliary air passageways used in the first embodiment are eliminated, and in lieu thereof the inflow and outflow air passageways are increased. In the second embodiment, the same reference signs used to designate elements in the first embodiment will be applied to the corresponding elements used in the second embodiment, and detailed description of the same elements will be omitted because the above description thereon seems to be self-explanatory. [0066]
  • A portion denoted by [0067] reference sign 21 is a medicator body of the second embodiment. Portions denoted by reference signs 22, 22 . . . are inflow air passageways formed in the medicator body 21. In the same manner as the inflow air passageway 5 of the first embodiment, each of the inflow air passageways 22 is constructed by an axial passage 22A and a radial passage 22B. However, the inflow air passageway 22 of the second embodiment is different from the inflow air passageway 5 of the first embodiment, in that four passageways (only three passageways are shown in the drawing) spaced from each other in the circumferential direction are provided.
  • Portions denoted by [0068] reference signs 23, 23 . . . are outflow air passageways formed in the medicator body 21. In the same manner as the outflow air passageway 6 of the first embodiment, each of the outflow air passageways 23 is constructed by a radial passage 23A, an axial passage 23B, and a diffusion chamber inflow passage 23C. However, the outflow air passageway 23 of the second embodiment is different from the outflow air passageway 6 of the first embodiment, in that four passageways (only three passageways are shown in the drawing) spaced from each other in the circumferential direction are provided.
  • The second embodiment as constructed above, can provide the same effects and operation as the first embodiment. In particular, in the second embodiment, the [0069] auxiliary air passageways 7 used in the first embodiment are eliminated, and in lieu thereof the four inflow air passageways 22 are provided, thus ensuring increased air flow of air flowing into the medical powder storage chamber 12. The increased air flow can effectively atomize the medical powder 16.
  • Hereinafter described in reference to FIGS. 9 and 12 is the third embodiment of the invention. The third embodiment is characterized in that a second medical powder diffusion chamber is provided between the cylindrical fit hole and the medical powder diffusion chamber. In the third embodiment, the same reference signs used to designate elements in the first embodiment will be applied to the corresponding elements used in the third embodiment, and detailed description of the same elements will be omitted because the above description thereon seems to be self-explanatory. [0070]
  • A portion denoted by [0071] reference sign 31 is a medicator body of the third embodiment. Substantially in the same manner as the medicator body 1 of the first embodiment, the medicator body 31 is formed therein with a cylindrical fit hole 32, an inhalant port 33, and others. However, the medicator body 31 of the third embodiment has a first medical powder diffusion chamber 34 and a second medical powder diffusion chamber 35, both provided between the cylindrical fit hole 32 and the inhalant port 33. The medicator body of the third embodiment is different from the medicator body 1 of the first embodiment, in that as a whole the medicator body of the third embodiment is formed as a longer body.
  • Portions denoted by [0072] reference signs 36, 36 . . . are inflow air passageways of the third embodiment. In the same manner as the inflow air passageway 5 of the first embodiment, each of the inflow air passageways 36 is constructed by an axial passage 36A and a radial passage 36B.
  • Portions denoted by [0073] reference signs 37, 37 . . . are two first outflow air passageways. Each of the first outflow air passageways 37 is constructed by radial passages 37A, 37A extending in the radial direction and opening to the cylindrical fit hole 32, axial passages 37B, 37B, communicating the respective tip end portions of the radial passages 37A and extending in the axial direction, and diffusion chamber inflow passages 37C, 37C formed as radial passages extending in the radial direction from the respective tip end portions of the axial passages 37B and opening to the first medical powder diffusion chamber 34.
  • Portions denoted by [0074] reference signs 38, 38 . . . are four second outflow air passageways of the third embodiment. Each of the second outflow air passageways 38 is constructed by diffusion chamber outflow passages 38A, 38A formed as radial passages extending in the radial direction and opening to the first medical powder diffusion chamber 34, axial passages 38B, 38B communicating the respective tip end portions of the diffusion chamber outflow passages 38A and extending in the axial direction, and diffusion chamber inflow passages 38C, 38C formed as radial passages extending in the radial direction from the tip end portions of the axial passages 38B and opening to the second medical powder diffusion chamber 35.
  • Portions denoted by [0075] reference signs 39, 39 are two auxiliary air passageways of the third embodiment. Each of the auxiliary air passageways 39 is constructed by axial passages 39A, 39A, and diffusion chamber inflow passages 39B, 39B formed as radial passages communicating the respective axial passages 39A and extending in the radial direction and opening to the first medical powder diffusion chamber 34.
  • Hereupon, as shown in FIG. 10, the diffusion [0076] chamber inflow passage 37C of the first inflow air passageway 37 opening to the first medical powder diffusion chamber 34 and the diffusion chamber inflow passage 39B of the auxiliary air passageway 39 are configured so that their tip end portions open at an eccentric position in which the inflow passage extends in the tangential direction of the first medical powder diffusion chamber 34.
  • As shown in FIG. 11, the diffusion [0077] chamber outflow passage 38A of the second inflow air passageway 38 opening to the first medical powder diffusion chamber 34 is configured, so that its tip end portion opens at an eccentric position in which the outflow passage extends in the tangential direction opposite to the diffusion chamber inflow passage 39B of the auxiliary air passageway 39, in order to facilitate the whirling flow produced within the first medical powder diffusion chamber 34 and passing through the diffusion chamber outflow passage 38A.
  • Furthermore, the diffusion [0078] chamber inflow passage 38C of the second outflow air passageway 38 opening to the second medical powder diffusion chamber 35 opens at an eccentric position in which the inflow passage extends in the same tangential direction as the diffusion chamber inflow passage 37C of the first outflow air passageway 37 and the diffusion chamber inflow passage 39B of the auxiliary air passageway 39.
  • The third embodiment as constructed above, can provide the same effects and operation as the first embodiment. In particular, in the third embodiment, as a granular medicine diffusing chamber, two medical powder diffusion chambers, namely the first and second medical [0079] powder diffusion chambers 34 and 35 are provided. Thus, even when the patient draws his or her breath while taking the inhalant port 33 in his or her mouse, under a particular condition where the medical powder 16 includes granulated medicines having a strong condensation property and the granulated medicines are adhered to each other to form a lump of granulated medicines, as can be seen from FIG. 12, it is possible to break and atomize the lump of medical powder by means of the two medical powder diffusion chambers 34 and 35. As a consequence, it is possible to inhale a specified amount of medical powder into lungs of the patient.
  • Hereinafter described in reference to FIGS. 13 and 15 is the fourth embodiment of the invention. The fourth embodiment is characterized in that a medical powder storage cylindrical member is constructed by a cylindrical portion axially slidably fitted into the inner peripheral surface of the cylindrical fit hole, a knob portion provided at the cylindrical portion and capable of taking out or putting in with respect to the medicator body, and inflow and outflow outlet ports through which the inflow and outflow air passageways are opened or closed by way of taking-out or putting-in operation of the knob portion. In the fourth embodiment, the same reference signs used to designate elements in the first embodiment will be applied to the corresponding elements used in the fourth embodiment, and detailed description of the same elements will be omitted because the above description thereon seems to be self-explanatory. [0080]
  • A portion denoted by [0081] reference sign 41 is a medicator body of the fourth embodiment. A portion denoted by reference sign 42 is a cylindrical fit hole formed in the medicator body 41. The cylindrical fit hole 42 has an axially extending bore opening at one axial end 41A and having a circular shape in cross section and having a bottom. The bottom portion 42A of the cylindrical fit hole is formed as a spherical surface. Also, the bottom portion 42A of the cylindrical fit hole 42 is formed with a C-shaped groove 42B. As shown in FIG. 14, the C-shaped groove 42B is configured in such a manner as to guide movably an engaged protruded portion 44A of a cylindrical portion 44 described later.
  • A portion denoted by [0082] reference sign 43 is a medical powder storage cylindrical member of the fourth embodiment, installed on the cylindrical fit hole 42 so that the medical powder storage cylindrical member is capable of taking out or putting in with respect to the opening end of the cylindrical fit hole 42. Substantially in the same manner as the medical powder storage cylindrical member 8 of the first embodiment, the medical powder storage cylindrical member 43 is mainly constructed by a cylindrical portion 44 inserted and fitted into the cylindrical fit hole 42, and a disc-shaped knob portion 45 provided at the base portion of the cylindrical portion 44. The interior of the cylindrical portion 44 is formed as a medical powder storage hole 46. A medical powder storage chamber 47 is defined between the medical powder storage hole 46 and the bottom portion 42A of the cylindrical fit hole 42.
  • However, the medical powder storage [0083] cylindrical member 43 of the fourth embodiment is different from the medical powder storage cylindrical member 43 of the first embodiment, in that the engaged protruded portion 4A, fitted to the C-shaped groove 42B of the cylindrical fit hole 42, is provided at the tip end portion of the cylindrical portion 44, inflow outlet port 44B and outflow outlet port 44C are formed in the cylindrical portion 44 at positions at which the inflow and outflow outlet ports respectively communicate the radial passage 5B of the inflow air passageway 5 and the radial passage 6A of the outflow air passageway 6 under a condition where the cylindrical portion 44 is extracted, and the atmospheric outlet ports used in the first embodiment are removed from the knob portion 45.
  • Hereupon, the C-shaped [0084] groove 42B formed in the cylindrical fit hole 42 of the medicator body 41 and the engaged protruded portion 44A formed in the cylindrical portion 44 of the medical powder storage cylindrical member 43 cooperate to each other to construct a stopper mechanism 48 serving as a stopper means for positioning the medical powder storage cylindrical member 43 during taking-out/putting-in operation of the medical powder storage cylindrical member 43 with respect to the medicator body 41.
  • The inhalant medicator of the fourth embodiment is constructed as previously discussed. Hereinbelow described in detail is the operation of the inhalant medication through which the patient inhales the medical powder. [0085]
  • In a state of the medicator prior to inhalant medication, as shown in FIG. 13, the [0086] air passageways 5 and 6 are closed by means of the cylindrical portion 44, while the atmospheric side of each of the air passageways 5 and 7 is closed by means of the knob portion 45.
  • Under this condition, when the inhalant medication has to be made, the medical powder storage [0087] cylindrical member 43 is rotated relative to the medicator body 41 in the direction indicated by the arrow A shown in FIGS. 13 and 14. Next, the cylindrical portion 44 of the medical powder storage cylindrical member 43 is extracted in the direction indicated by the arrow B. Thereafter, with rotary motion of the medical powder storage cylindrical member 43, returning the medical powder storage cylindrical member 43 to the direction indicated by the arrow C, as shown in FIG. 15, it is possible to position in such a manner as to establish fluid communication between the air passageway 5 and the inflow outlet port 44B and fluid communication between the air passageway 6 and the outflow outlet port 44C. Under this condition, when the patient draws his or her breath while taking the inhalant port 3 in his or her mouse, the medical powder 16 can be inhaled.
  • The fourth embodiment as constructed above, can provide the same effects and operation as the first embodiment. [0088]
  • As described above, in the third embodiment, the [0089] auxiliary air passageways 39, 39 through which the first medical powder diffusion chamber is communicated with the atmospheric side, is formed in the medicator body 31. However, the present invention is not limited to the particular embodiments shown and described herein. For instance, as can be seen from the first modification shown in FIG. 16, another auxiliary air passageways 39, 39 (only one passageway is shown in the drawing) intercommunicating the atmospheric side and the second medical powder diffusion chamber 35, may be formed in the medicator body 31, independently of the auxiliary air passageways 39, 39 intercommunicating the atmospheric side and the first medical powder diffusion chamber 34.
  • Additionally, in the first embodiment, the [0090] inflow air passageway 5 is constructed by the axial passage 5A and the radial passage 5B. In lieu thereof, as indicated by the two-dotted line shown in FIG. 1, an inflow air passageway 5′ is formed so that the inflow air passageway extends in the radial direction and opens to a curved surface of the medicator body 1. In the same manner, such a construction can be applied to the other embodiments.
  • Additionally, in the first, second, and fourth embodiments one medical [0091] powder diffusion chamber 4 is provided, whereas in the second embodiment and the modification two medical powder diffusion chambers 34, 35 are provided. However, the invention is not limited to the particular embodiments shown and described herein. Alternatively, three or more medical powder diffusion chambers may be provided. It is preferable that the number of the medical powder diffusion chambers is determined or set depending on characteristics or properties of medical powder (such as a condensation property).
  • On the other hand, as discussed above, in the first embodiment, the [0092] medical powder 16 is encapsulated within the cylindrical fit hole 2 at a time when the medicator body 1 and the medical powder storage cylindrical member 8 are assembled to each other. In lieu thereof, the medical powder 16 may be charged into the cylindrical fit hole 2 just before the operation of inhalant medication. In the same manner, such a construction can be applied to the other embodiments.
  • Additionally, in each of the embodiments, the opening and closing of the [0093] inflow air passageways 5, 22, 36 with respect to the atmospheric side are made by the respective knob portions 10, 45 of the medical powder storage cylindrical members 8, 43. The invention is not limited to the particular embodiments shown and described herein. For instance, the knob portion is configured to have the same diameter dimension as the cylindrical portion. That is, it is unnecessary to always close the atmospheric outlet port of the inflow air passageway.
  • Additionally, in each of the embodiments, the [0094] inflow air passageways 5, 22, 36 and the outflow air passageways 6, 23, 37 are formed so that these passageways extend in the radial direction towards the central portion of the cylindrical fit holes 2, 32, 42. In lieu thereof, these air passageways may be constructed so that the air passageways open to the respective cylindrical fit holes at eccentric positions in which the air passageways extend in the respective tangential directions of the cylindrical fit holes.
  • Furthermore, in the first embodiment, the medical [0095] powder storage chamber 12 is defined between the bottom portion 2A of the cylindrical fit hole 2 and the medical powder storage hole 11 by fitting the cylindrical portion 9 of the medical powder storage member 8 into the cylindrical fit hole 2 of the medicator body 1. The invention is not limited to the particular embodiments shown and described herein. For instance, as can be seen from the second modification shown in FIG. 17, a medical powder storage hole 54 may be provided by defining the medical powder storage chamber by way of only a cylindrical portion 52 of a medical powder storage cylindrical member 51. In this case, it is preferable that the bottom face of the cylindrical fit hole of the medicator body is designed to be flat. In the same manner, such a construction can be applied to the other embodiments.
  • As explained above, according to the invention as claimed in [0096] claim 1, under a condition where the inflow air passageway and the outflow air passageway are closed with respect to the medical powder storage hole by means of the medical powder storage cylindrical member, it is possible to prevent the medical powder stored in the medical powder storage hole from flowing to the outside via the air passageways. Also, when the medical powder has to be inhaled, the inflow air passageway and the outflow air passageway are opened to the medical powder storage hole by operating the medical powder storage cylindrical member. Under these conditions, the patient draws his or her breath while taking the inhalant port in his or her mouse, atmosphere flown into the inflow air passageway flows into the cylindrical fit hole, taking the form of air flow. As a result of this, the medical powder in the cylindrical fit hole can be atomized. Thus, in a blended condition of the medical powder with air flow, the mixture of the incoming air and medical powder passes through the outflow air passageway and then flows towards within the inhalant port, and thus the patient can inhale the medical powder through the inhalant port into lungs of the patient.
  • Additionally, the inhalant medicator of the invention is constructed by two component parts, namely the medicator body and the medical powder storage cylindrical member, and also it is possible to open and close each of the air passageways with respect to the medical powder storage hole by means of the medical powder storage cylindrical member, thereby reducing production costs, and consequently ensuring reduced economical burden of the patient. In addition, even when the medical powder storage hole is filled with medical powder in advance, it is possible to prevent the medical powder stored in the medical powder storage hole from flowing to the outside. Thus, the inhalant medicator of the invention can be suitably used as a throwaway type. [0097]
  • According to the invention as claimed in [0098] claim 2, the patient can inhale a specified amount of medical powder into lungs. This enhances medical benefits of the powdered or granular medicines, and also enhances the reliability of the inhalant medicator.
  • According to the invention as claimed in [0099] claim 3, it is possible to produce or create whirling flow within the medical powder diffusion chamber by virtue of air flow passing through the air passageway and then flowing into the medical powder diffusion chamber. Even when the medical powder includes granulated medicines having a strong condensation property, it is possible to effectively diffuse and atomize the medical powder by way of the whirling flow, thus more remarkably enhancing an inhalation efficiency of the medical powder.
  • According to the invention as claimed in [0100] claim 4, the inflow and outflow air passageways can be respectively opened or closed by means of the inflow outlet port and the outflow outlet port by rotating the medical powder storage cylindrical member relative to the medicator body while grasping the knob portion. Thus, under a condition where the inflow air passageway and the outflow air passageway are respectively closed by the inflow outlet port and the outflow outlet port, it is possible to prevent the medical powder to flow out.
  • According to the invention as claimed in [0101] claim 5, the inflow and outflow air passageways can be respectively opened or closed through the inflow outlet port and the outflow outlet port by taking out or putting in the medical powder storage cylindrical member relative to the medicator body, while grasping the knob portion. Thus, under a condition where the inflow air passageway and the outflow air passageway are respectively closed by the inflow outlet port and the outflow outlet port, it is possible to prevent the medical powder to flow out.
  • According to the invention as claimed in [0102] claim 6, when operating the medical powder storage cylindrical member, the stopper means can position the medical powder storage cylindrical member at the position where the inflow outlet port and the inflow air passageway are communicated with each other and the outflow outlet port and the outflow air passageway are communicated with each other. Thus, it is possible to easily and certainly open or close the inflow and outflow air passageways, thus ensuring enhanced operability or easy manipulation.

Claims (11)

1. An inhalant medicator comprising:
a medicator body formed with a cylindrical fit hole opening at one axial end and formed at the other axial end with an inhalant port;
an inflow air passageway formed in the medicator body for supplying air into the cylindrical fit hole;
an outflow air passageway formed in the medicator body for discharging air from the cylindrical fit hole into the inhalant port; and
a medical powder storage cylindrical member having a cylindrical portion defining therein a medical powder storage hole whose internal space stores a medical powder and capable of opening and closing each of the inflow air passageway and the outflow air passageway with respect to the medical powder storage hole by external operation.
2. The inhalant medicator as claimed in claim 1, wherein at least one medical powder diffusion chamber is formed in the medicator body and located between the cylindrical fit hole and the inhalant port for diffusing the medical powder flowing out of the outflow air passageway.
3. The inhalant medicator as claimed in claim 2, wherein the air passageway communicating with the medical powder diffusion chamber is formed to open to the medical powder diffusion chamber at an eccentric position in which the air passageway extends in a tangential direction of the medical powder diffusion chamber.
4. The inhalant medicator as claimed in claim 1, wherein the medical powder storage cylindrical member comprises a cylindrical portion rotatably fitted into the inner peripheral wall of the cylindrical fit hole and a knob portion provided at the cylindrical portion and operated rotatably with respect to the medicator body, and inflow and outflow outlet ports through which the inflow and outflow air passageways are opened or closed by way of rotary operation of the knob portion.
5. The inhalant medicator as claimed in claim 2, wherein the medical powder storage cylindrical member comprises a cylindrical portion rotatably fitted into the inner peripheral wall of the cylindrical fit hole and a knob portion provided at the cylindrical portion and operated rotatably with respect to the medicator body, and inflow and outflow outlet ports through which the inflow and outflow air passageways are opened or closed by way of rotary operation of the knob portion.
6. The inhalant medicator as claimed in claim 3, wherein the medical powder storage cylindrical member comprises a cylindrical portion rotatably fitted into the inner peripheral wall of the cylindrical fit hole and a knob portion provided at the cylindrical portion and operated rotatably with respect to the medicator body, and inflow and outflow outlet ports through which the inflow and outflow air passageways are opened or closed by way of rotary operation of the knob portion.
7. The inhalant medicator as claimed in claim 1, wherein the medical powder storage cylindrical member comprises a cylindrical portion axially slidably fitted into the inner peripheral wall of the cylindrical fit hole, a knob portion provided at the cylindrical portion and capable of taking out or putting in with respect to the medicator body, and inflow and outflow outlet ports through which the inflow and outflow air passageways are opened or closed by way of taking-out or putting-in operation of the knob portion.
8. The inhalant medicator as claimed in claim 2, wherein the medical powder storage cylindrical member comprises a cylindrical portion axially slidably fitted into the inner peripheral wall of the cylindrical fit hole, a knob portion provided at the cylindrical portion and capable of taking out or putting in with respect to the medicator body, and inflow and outflow outlet ports through which the inflow and outflow air passageways are opened or closed by way of taking-out or putting-in operation of the knob portion.
9. The inhalant medicator as claimed in claim 3, wherein the medical powder storage cylindrical member comprises a cylindrical portion axially slidably fitted into the inner peripheral wall of the cylindrical fit hole, a knob portion provided at the cylindrical portion and capable of taking out or putting in with respect to the medicator body, and inflow and outflow outlet ports through which the inflow and outflow air passageways are opened or closed by way of taking-out or putting-in operation of the knob portion.
10. The inhalant medicator as claimed in claim 4, wherein a stopper means is provided between the medicator body and the medical powder storage cylindrical member for positioning the medical powder storage cylindrical member at a position where the inflow outlet port is communicated with the inflow air passageway and the outflow outlet port is communicated with the outflow air passageway when operating the medical powder storage cylindrical member.
11. The inhalant medicator as claimed in claim 7, wherein a stopper means is provided between the medicator body and the medical powder storage cylindrical member for positioning the medical powder storage cylindrical member at a position where the inflow outlet port is communicated with the inflow air passageway and the outflow outlet port is communicated with the outflow air passageway when operating the medical powder storage cylindrical member.
US09/998,418 1999-01-27 2001-12-03 Inhalant medicator Abandoned US20020033177A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
US09/998,418 US20020033177A1 (en) 1999-01-27 2001-12-03 Inhalant medicator

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
JP11-19145 1999-01-27
JP11019145A JP2000217917A (en) 1999-01-27 1999-01-27 Inhaler type medicine administration tool
US09/623,478 US6371111B1 (en) 1999-01-27 1999-12-27 Inhalation type drug dispenser
US09/998,418 US20020033177A1 (en) 1999-01-27 2001-12-03 Inhalant medicator

Related Parent Applications (2)

Application Number Title Priority Date Filing Date
US09/623,478 Continuation US6371111B1 (en) 1999-01-27 1999-12-27 Inhalation type drug dispenser
PCT/JP1999/007305 Continuation WO2000044426A1 (en) 1999-01-27 1999-12-27 Inhalation type drug dispenser

Publications (1)

Publication Number Publication Date
US20020033177A1 true US20020033177A1 (en) 2002-03-21

Family

ID=11991291

Family Applications (2)

Application Number Title Priority Date Filing Date
US09/623,478 Expired - Fee Related US6371111B1 (en) 1999-01-27 1999-12-27 Inhalation type drug dispenser
US09/998,418 Abandoned US20020033177A1 (en) 1999-01-27 2001-12-03 Inhalant medicator

Family Applications Before (1)

Application Number Title Priority Date Filing Date
US09/623,478 Expired - Fee Related US6371111B1 (en) 1999-01-27 1999-12-27 Inhalation type drug dispenser

Country Status (5)

Country Link
US (2) US6371111B1 (en)
EP (1) EP1068874B1 (en)
JP (1) JP2000217917A (en)
DE (1) DE69929539T2 (en)
WO (1) WO2000044426A1 (en)

Cited By (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6595210B2 (en) * 2000-11-27 2003-07-22 Unisia Jecs Corporation Inhalator for administering powder composition
WO2005084735A1 (en) * 2004-03-05 2005-09-15 Boehringer Ingelheim International Gmbh Powder inhaler comprising a multi-channel nozzle
WO2005089843A1 (en) * 2004-03-18 2005-09-29 Roberto Oliva Inhaler for preparations in powder form
WO2005113043A1 (en) * 2004-05-19 2005-12-01 Cipla Limited Medicament inhaler device
WO2005118035A1 (en) * 2004-05-28 2005-12-15 Quadrant Technologies Limited Unit dose dry powder inhales
US20070060868A1 (en) * 2003-10-09 2007-03-15 Bioactis Limited Device to deliver a powdery medicine into nasal cavity
EP1778322A1 (en) * 2004-07-26 2007-05-02 1355540 Ontario Inc. Powder inhaler featuring reduced compaction inhaler
US20070272763A1 (en) * 2004-10-06 2007-11-29 Boehringer Ingelheim International Gmbh Dispensing Device, Storage Device and Method for Dispensing Powder
WO2008001132A1 (en) 2006-06-27 2008-01-03 Brintech International Limited Inhaler
US20090235930A1 (en) * 2004-05-28 2009-09-24 Young Matthew E Unit dose dry powder inhaler
CN102631736A (en) * 2011-02-14 2012-08-15 中国人民解放军军事医学科学院毒物药物研究所 Dry powder suction device
US20120211007A1 (en) * 2002-04-09 2012-08-23 Boehringer Ingelheim Pharma Gmbh & Co. Kg Inhaler for the administration of an anticholinergic
US9192675B2 (en) 2008-06-13 2015-11-24 Mankind Corporation Dry powder inhaler and system for drug delivery
US9283193B2 (en) 2005-09-14 2016-03-15 Mannkind Corporation Method of drug formulation based on increasing the affinity of crystalline microparticle surfaces for active agents
US9364436B2 (en) 2011-06-17 2016-06-14 Mannkind Corporation High capacity diketopiperazine microparticles and methods
US9364619B2 (en) 2008-06-20 2016-06-14 Mannkind Corporation Interactive apparatus and method for real-time profiling of inhalation efforts
US9610351B2 (en) 2011-10-24 2017-04-04 Mannkind Corporation Methods and compositions for treating pain
US9630930B2 (en) 2009-06-12 2017-04-25 Mannkind Corporation Diketopiperazine microparticles with defined specific surface areas
US9655850B2 (en) 2008-12-29 2017-05-23 Mannkind Corporation Substituted diketopiperazine analogs for use as drug delivery agents
US9662461B2 (en) 2008-06-13 2017-05-30 Mannkind Corporation Dry powder drug delivery system and methods
US9675674B2 (en) 2004-08-23 2017-06-13 Mannkind Corporation Diketopiperazine salts for drug delivery and related methods
US9700690B2 (en) 2002-03-20 2017-07-11 Mannkind Corporation Inhalation apparatus
US9706944B2 (en) 2009-11-03 2017-07-18 Mannkind Corporation Apparatus and method for simulating inhalation efforts
US9796688B2 (en) 2004-08-20 2017-10-24 Mannkind Corporation Catalysis of diketopiperazine synthesis
US9802012B2 (en) 2012-07-12 2017-10-31 Mannkind Corporation Dry powder drug delivery system and methods
US9801925B2 (en) 1999-06-29 2017-10-31 Mannkind Corporation Potentiation of glucose elimination
US9925144B2 (en) 2013-07-18 2018-03-27 Mannkind Corporation Heat-stable dry powder pharmaceutical compositions and methods
US9943571B2 (en) 2008-08-11 2018-04-17 Mannkind Corporation Use of ultrarapid acting insulin
US9983108B2 (en) 2009-03-11 2018-05-29 Mannkind Corporation Apparatus, system and method for measuring resistance of an inhaler
US10130581B2 (en) 2006-02-22 2018-11-20 Mannkind Corporation Method for improving the pharmaceutic properties of microparticles comprising diketopiperazine and an active agent
US10159644B2 (en) 2012-10-26 2018-12-25 Mannkind Corporation Inhalable vaccine compositions and methods
US10307464B2 (en) 2014-03-28 2019-06-04 Mannkind Corporation Use of ultrarapid acting insulin
US10342938B2 (en) 2008-06-13 2019-07-09 Mannkind Corporation Dry powder drug delivery system
US10421729B2 (en) 2013-03-15 2019-09-24 Mannkind Corporation Microcrystalline diketopiperazine compositions and methods
US10561806B2 (en) 2014-10-02 2020-02-18 Mannkind Corporation Mouthpiece cover for an inhaler
US10625034B2 (en) 2011-04-01 2020-04-21 Mannkind Corporation Blister package for pharmaceutical cartridges
US11446127B2 (en) 2013-08-05 2022-09-20 Mannkind Corporation Insufflation apparatus and methods

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2365777A (en) * 2000-05-16 2002-02-27 Norton Healthcare Ltd Drug delivery device for airborne medicament
FI20002363A0 (en) * 2000-10-27 2000-10-27 Orion Yhtymae Oyj powder inhaler
FI20011317A0 (en) * 2001-06-20 2001-06-20 Orion Corp The powder inhaler
GB0227128D0 (en) * 2002-11-20 2002-12-24 Glaxo Group Ltd A capsule
GB0303870D0 (en) * 2003-02-20 2003-03-26 Norton Healthcare Ltd Pre-metered dose magazine for breath-actuated dry powder inhaler
PL1610850T3 (en) 2003-04-09 2012-11-30 Novartis Ag Aerosolization apparatus with air inlet shield
US8869794B1 (en) 2003-04-09 2014-10-28 Novartis Pharma Ag Aerosolization apparatus with capsule puncturing member
DE102004041524B4 (en) * 2004-08-27 2013-03-21 Sanofi Sa Inhaler for powdery, in particular medicinal substances
PL370285A1 (en) * 2004-09-23 2006-04-03 Glaxosmithkline Pharmaceuticals Spółka Akcyjna Powder inhaler
JP2006130143A (en) * 2004-11-08 2006-05-25 Hitachi Ltd Inhalation administration device and medicine cartridge
CN100431634C (en) * 2005-04-04 2008-11-12 陈庆堂 Dry powder aerosolizing inhalator
AU2013205495B2 (en) * 2006-02-17 2015-11-26 Sanofi Sa Dispersing unit
DE102006007495A1 (en) 2006-02-17 2007-08-23 Siegfried Generics International Ag Dispersion unit e.g. for medical powder inhalator and aerosol dispersion, uses annular guide chamber to direct entering powder flow in mainly radial direction
WO2008101992A1 (en) * 2007-02-21 2008-08-28 Novo Nordisk A/S Aerosol generating device with air flow control
JP4963084B2 (en) * 2007-05-31 2012-06-27 株式会社吉野工業所 Suction dispenser
IN2014DN06108A (en) * 2011-12-16 2015-08-14 Indosys Ltd
EP2944343A1 (en) * 2014-05-15 2015-11-18 AstraZeneca AB Dry powder inhaler
ES2760943T3 (en) * 2016-05-23 2020-05-18 Presspart Mfg Ltd Dry powder inhaler
KR20210117266A (en) * 2019-01-14 2021-09-28 필립모리스 프로덕츠 에스.에이. dry powder inhaler
IT202100024582A1 (en) * 2021-09-24 2023-03-24 Bazzica Eng S R L INHALER DEVICE AND INHALATION SYSTEM INCLUDING SAME
WO2023047358A1 (en) * 2021-09-24 2023-03-30 Bazzica Engineering S.R.L. Dry powder inhaler
IT202200019479A1 (en) 2022-09-22 2024-03-22 Bazzica Eng S R L DRY POWDER INHALER

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4175556A (en) * 1978-04-07 1979-11-27 Freezer Winthrop J Inhaler with flow-through cap
EP0005585B1 (en) * 1978-05-03 1981-08-12 FISONS plc Inhalation device
SE448277B (en) * 1985-04-12 1987-02-09 Draco Ab INDICATOR DEVICE WITH A DOSAGE DEVICE FOR MEDICINAL PRODUCTS
AT384552B (en) * 1985-08-01 1987-12-10 Hurka Wilhelm INHALATION DEVICE FOR DOSING AND DISTRIBUTING SOLID BODIES INTO THE BREATHING AIR
US5176132A (en) * 1989-05-31 1993-01-05 Fisons Plc Medicament inhalation device and formulation
FI84698C (en) * 1989-06-16 1992-01-10 Huhtamaeki Oy ANORDINATION FOR FINANCING OF AGGLOMERIA AV EN ENKELDOS AV ETT LAEKEMEDELPREPARAT I PULVERFORM.
GB9027234D0 (en) * 1990-12-15 1991-02-06 Harris Pharma Ltd An inhalation device
DE59107894D1 (en) * 1991-03-21 1996-07-11 Ritzau Pari Werk Gmbh Paul Nebulizers, in particular for use in devices for inhalation therapy
US5243970A (en) * 1991-04-15 1993-09-14 Schering Corporation Dosing device for administering metered amounts of powdered medicaments to patients
DE4211475A1 (en) * 1991-12-14 1993-06-17 Asta Medica Ag POWDER INHALATOR
US5394868A (en) * 1992-06-25 1995-03-07 Schering Corporation Inhalation device for powdered medicaments
SE9302550D0 (en) * 1993-07-30 1993-07-30 Ernst Hoerlin POWDER INHALES
JP3372105B2 (en) * 1994-05-26 2003-01-27 株式会社日立ユニシアオートモティブ Inhalation type dispenser
JP3388896B2 (en) 1994-08-08 2003-03-24 株式会社日立ユニシアオートモティブ Inhalation type dispenser
JPH0889576A (en) 1994-09-27 1996-04-09 Unisia Jecs Corp Inhalation type medication device
US5901703A (en) 1995-02-06 1999-05-11 Unisia Jecs Corporation Medicine administering device for nasal cavities
JP3308425B2 (en) 1995-03-10 2002-07-29 株式会社ユニシアジェックス Nasal administration device
JP3320261B2 (en) 1995-06-01 2002-09-03 株式会社ユニシアジェックス Inhaler type dispenser
JP3434396B2 (en) 1995-06-30 2003-08-04 株式会社日立ユニシアオートモティブ Nasal administration device
JP3317823B2 (en) 1995-08-11 2002-08-26 株式会社ユニシアジェックス Dosing device
JP3317827B2 (en) 1995-10-09 2002-08-26 株式会社ユニシアジェックス Dosing device
US5699789A (en) * 1996-03-11 1997-12-23 Hendricks; Mark R. Dry powder inhaler
JP3328132B2 (en) 1996-03-21 2002-09-24 株式会社ユニシアジェックス Inhaler type dispenser
JPH09253208A (en) 1996-03-21 1997-09-30 Unisia Jecs Corp Medicator for nasal cavity
ES2205210T3 (en) * 1996-04-29 2004-05-01 Quadrant Technologies Ltd. INHALATION PROCEDURES FOR DRY POWDER.
SE9700940D0 (en) * 1997-03-14 1997-03-14 Astra Ab Powder inhales IV
JP3530004B2 (en) 1998-02-06 2004-05-24 株式会社日立ユニシアオートモティブ Inhalation type dispenser

Cited By (68)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9801925B2 (en) 1999-06-29 2017-10-31 Mannkind Corporation Potentiation of glucose elimination
US20030188747A1 (en) * 2000-11-27 2003-10-09 Unisia Jecs Corporation Inhalator, a powder composition and a process for administering the powder composition using inhalators
US6595210B2 (en) * 2000-11-27 2003-07-22 Unisia Jecs Corporation Inhalator for administering powder composition
US9700690B2 (en) 2002-03-20 2017-07-11 Mannkind Corporation Inhalation apparatus
US20160279356A1 (en) * 2002-04-09 2016-09-29 Boehringer Ingelheim Pharma Gmbh & Co. Kg Inhaler for the administration of an anticholinergic
US20140116435A1 (en) * 2002-04-09 2014-05-01 Boehringer Ingelheim Pharma Gmbh & Co. Kg Inhaler for the administration of an anticholinergic
US20120211007A1 (en) * 2002-04-09 2012-08-23 Boehringer Ingelheim Pharma Gmbh & Co. Kg Inhaler for the administration of an anticholinergic
US20070060868A1 (en) * 2003-10-09 2007-03-15 Bioactis Limited Device to deliver a powdery medicine into nasal cavity
US7722566B2 (en) * 2003-10-09 2010-05-25 Shin Nippon Biomedical Laboratories, Ltd. Device to deliver a powdery medicine into nasal cavity
WO2005084735A1 (en) * 2004-03-05 2005-09-15 Boehringer Ingelheim International Gmbh Powder inhaler comprising a multi-channel nozzle
US20050263151A1 (en) * 2004-03-05 2005-12-01 Boehringer Ingelheim International Gmbh Powder inhaler having a nozzle with a plurality of channels
US7984713B2 (en) 2004-03-05 2011-07-26 Boehringer Ingelheim International Gmbh Powder inhaler having a nozzle with a plurality of channels
WO2005089843A1 (en) * 2004-03-18 2005-09-29 Roberto Oliva Inhaler for preparations in powder form
US20070277821A1 (en) * 2004-03-18 2007-12-06 Roberto Oliva Inhaler For Preparations In Powder Form
US8302601B2 (en) 2004-03-18 2012-11-06 Roberto Oliva Inhaler for preparations in powder form
WO2005113043A1 (en) * 2004-05-19 2005-12-01 Cipla Limited Medicament inhaler device
US20090235931A1 (en) * 2004-05-28 2009-09-24 Young Matthew E Unit dose dry powder inhaler
US20090235930A1 (en) * 2004-05-28 2009-09-24 Young Matthew E Unit dose dry powder inhaler
US7556035B2 (en) 2004-05-28 2009-07-07 Quadrant Technologies Limited Unit dose dry powder inhaler
WO2005118035A1 (en) * 2004-05-28 2005-12-15 Quadrant Technologies Limited Unit dose dry powder inhales
US20080142006A1 (en) * 2004-07-26 2008-06-19 1355540 Ontario Inc. Powder Inhaler Featuring Reduced Compaction Inhaler
US8171930B2 (en) * 2004-07-26 2012-05-08 135540 Ontario Inc. Powder inhaler featuring reduced compaction inhaler
EP1778322A4 (en) * 2004-07-26 2011-01-19 1355540 Ontario Inc Powder inhaler featuring reduced compaction inhaler
EP1778322A1 (en) * 2004-07-26 2007-05-02 1355540 Ontario Inc. Powder inhaler featuring reduced compaction inhaler
US9796688B2 (en) 2004-08-20 2017-10-24 Mannkind Corporation Catalysis of diketopiperazine synthesis
US10130685B2 (en) 2004-08-23 2018-11-20 Mannkind Corporation Diketopiperazine salts for drug delivery and related methods
US9675674B2 (en) 2004-08-23 2017-06-13 Mannkind Corporation Diketopiperazine salts for drug delivery and related methods
US20070272763A1 (en) * 2004-10-06 2007-11-29 Boehringer Ingelheim International Gmbh Dispensing Device, Storage Device and Method for Dispensing Powder
US9283335B2 (en) * 2004-10-06 2016-03-15 Boehringer Ingelheim International Gmbh Dispensing device, storage device and method for dispensing powder
US9089658B2 (en) * 2004-10-06 2015-07-28 Boehringer Ingelheim International Gmbh Dispensing device, storage device and method for dispensing powder
US20120222675A1 (en) * 2004-10-06 2012-09-06 Boehringer Ingeleim International Gmbh Dispensing device, storage device and method for dispensing powder
US9283193B2 (en) 2005-09-14 2016-03-15 Mannkind Corporation Method of drug formulation based on increasing the affinity of crystalline microparticle surfaces for active agents
US10143655B2 (en) 2005-09-14 2018-12-04 Mannkind Corporation Method of drug formulation
US9446001B2 (en) 2005-09-14 2016-09-20 Mannkind Corporation Increasing drug affinity for crystalline microparticle surfaces
US9717689B2 (en) 2005-09-14 2017-08-01 Mannkind Corporation Method of drug formulation based on increasing the affinity of crystalline microparticle surfaces for active agents
US10130581B2 (en) 2006-02-22 2018-11-20 Mannkind Corporation Method for improving the pharmaceutic properties of microparticles comprising diketopiperazine and an active agent
US8201555B2 (en) 2006-06-27 2012-06-19 Brintech International Limited Inhaler
US20090308388A1 (en) * 2006-06-27 2009-12-17 Brindra Paul Singh Chawla Inhaler
WO2008001132A1 (en) 2006-06-27 2008-01-03 Brintech International Limited Inhaler
US9446133B2 (en) 2008-06-13 2016-09-20 Mannkind Corporation Dry powder inhaler and system for drug delivery
US10342938B2 (en) 2008-06-13 2019-07-09 Mannkind Corporation Dry powder drug delivery system
US9662461B2 (en) 2008-06-13 2017-05-30 Mannkind Corporation Dry powder drug delivery system and methods
US10751488B2 (en) 2008-06-13 2020-08-25 Mannkind Corporation Dry powder inhaler and system for drug delivery
US10201672B2 (en) 2008-06-13 2019-02-12 Mannkind Corporation Dry powder inhaler and system for drug delivery
US9192675B2 (en) 2008-06-13 2015-11-24 Mankind Corporation Dry powder inhaler and system for drug delivery
US9511198B2 (en) 2008-06-13 2016-12-06 Mannkind Corporation Dry powder inhaler and system for drug delivery
US9339615B2 (en) 2008-06-13 2016-05-17 Mannkind Corporation Dry powder inhaler and system for drug delivery
US10675421B2 (en) 2008-06-20 2020-06-09 Mannkind Corporation Interactive apparatus and method for real-time profiling of inhalation efforts
US9364619B2 (en) 2008-06-20 2016-06-14 Mannkind Corporation Interactive apparatus and method for real-time profiling of inhalation efforts
US9943571B2 (en) 2008-08-11 2018-04-17 Mannkind Corporation Use of ultrarapid acting insulin
US10172850B2 (en) 2008-12-29 2019-01-08 Mannkind Corporation Substituted diketopiperazine analogs for use as drug delivery agents
US9655850B2 (en) 2008-12-29 2017-05-23 Mannkind Corporation Substituted diketopiperazine analogs for use as drug delivery agents
US9983108B2 (en) 2009-03-11 2018-05-29 Mannkind Corporation Apparatus, system and method for measuring resistance of an inhaler
US9630930B2 (en) 2009-06-12 2017-04-25 Mannkind Corporation Diketopiperazine microparticles with defined specific surface areas
US9706944B2 (en) 2009-11-03 2017-07-18 Mannkind Corporation Apparatus and method for simulating inhalation efforts
CN102631736A (en) * 2011-02-14 2012-08-15 中国人民解放军军事医学科学院毒物药物研究所 Dry powder suction device
US10625034B2 (en) 2011-04-01 2020-04-21 Mannkind Corporation Blister package for pharmaceutical cartridges
US10130709B2 (en) 2011-06-17 2018-11-20 Mannkind Corporation High capacity diketopiperazine microparticles and methods
US9364436B2 (en) 2011-06-17 2016-06-14 Mannkind Corporation High capacity diketopiperazine microparticles and methods
US10258664B2 (en) 2011-10-24 2019-04-16 Mannkind Corporation Methods and compositions for treating pain
US9610351B2 (en) 2011-10-24 2017-04-04 Mannkind Corporation Methods and compositions for treating pain
US9802012B2 (en) 2012-07-12 2017-10-31 Mannkind Corporation Dry powder drug delivery system and methods
US10159644B2 (en) 2012-10-26 2018-12-25 Mannkind Corporation Inhalable vaccine compositions and methods
US10421729B2 (en) 2013-03-15 2019-09-24 Mannkind Corporation Microcrystalline diketopiperazine compositions and methods
US9925144B2 (en) 2013-07-18 2018-03-27 Mannkind Corporation Heat-stable dry powder pharmaceutical compositions and methods
US11446127B2 (en) 2013-08-05 2022-09-20 Mannkind Corporation Insufflation apparatus and methods
US10307464B2 (en) 2014-03-28 2019-06-04 Mannkind Corporation Use of ultrarapid acting insulin
US10561806B2 (en) 2014-10-02 2020-02-18 Mannkind Corporation Mouthpiece cover for an inhaler

Also Published As

Publication number Publication date
DE69929539D1 (en) 2006-04-06
DE69929539T2 (en) 2006-08-10
JP2000217917A (en) 2000-08-08
EP1068874B1 (en) 2006-01-18
US6371111B1 (en) 2002-04-16
WO2000044426A1 (en) 2000-08-03
EP1068874A4 (en) 2004-08-11
EP1068874A1 (en) 2001-01-17

Similar Documents

Publication Publication Date Title
US6371111B1 (en) Inhalation type drug dispenser
EP1475115B1 (en) Dry powder inhaler
US5752505A (en) Inhalation-type medicine delivery device
US6408846B1 (en) Inhalation type drug dispenser
EP0973571B1 (en) Inhalant medicator
EP0898978B1 (en) Suction type medicator
EP1464356B1 (en) Inhalator
NZ540936A (en) Inhalation device for transpulmonary administration
US6341605B1 (en) Inhalant medicator
JP3328131B2 (en) Inhaler type dispenser
JP3845530B2 (en) Inhaler
JPH09322938A (en) Inhalation type medicator
JP3315031B2 (en) Dosing device
JP2001161788A (en) Blister pack
JP2000217920A (en) Inhaler type medicine administration tool
JP3547612B2 (en) Inhalation type dispenser
JP3434402B2 (en) Dosing device
JPH1028735A (en) Dosing device for nasal cavity
JPH09253209A (en) Inhalation type medicator
JPH09253211A (en) Inhalation type medicator
JPH09140792A (en) Medicator
JPH11267213A (en) Inhalation type medicine administer
JP2000217918A (en) Inhaler type medicine administration tool
JPH09182792A (en) Medicator
JPH09248341A (en) Chemical administration device for nostril

Legal Events

Date Code Title Description
STCB Information on status: application discontinuation

Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION